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ABBREVIATIONS
ALT Argon laser trabeculoplasty
BP Blood pressure
ExOHT Exfoliation syndrome with ocular hypertension
ExG Exfoliation glaucoma
ExS Exfoliation syndrome
HUEH Helsinki University Eye Hospital
HRT Heidelberg Retina Tomograph (Heidelberg Engineering GmbH, Heidelberg,
Germany)
HRF Heidelberg Retina Flowmeter (Heidelberg Engineering GmbH)
IOP Intraocular pressure
LV Loss variance
MD Mean defect
MS Mean sensitivity
NTG Normal tension glaucoma
OAG Open-angle glaucoma
OHT Ocular hypertension
ONH Optic nerve head
PRC Partial regression coefficient
POAG Primary open-angle glaucoma
r Pearson correlation or Spearman’s rank correlation coefficient
ROC Receiver operating characteristic analysis
RNFL Retinal nerve fibre layer
SLDF Scanning laser Doppler flowmetry
SLO Scanning laser ophthalmoscopy
TIA Transient ischaemic attack
VF Visual field
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1. ABSTRACT
The present investigation on a hospital basis was begun to study the effect of IOP reduction
on the risk for progression and factors affecting target pressure (I). Risk factors for
progression of glaucoma were studied on 139 eyes of 139 patients with exfoliation
syndrome (ExS) and ocular hypertension (ExOHT) or glaucoma (ExG). After a mean
(±SD) follow-up time of 5.2 ± 3.6 years (range 1.0-19.8 years), progression was detected in
63 eyes (45.3%), with 76 eyes (54.7%) showing no progression. In order to control the
length of follow-up and the different number of available intraocular pressure (IOP)
readings between two follow-up visits, a weighted mean IOP was calculated to describe the
IOP level between two successive visits. Multivariate survival analysis detected increased
age (relative risk 1.042; P-value 0.043), increased mean weighted IOP (1.076; <0.001), and
increased stage of glaucoma (1.436; <0.001) as risk factors for progression. History of
trabeculectomy was associated with decreased relative risk for progression (0.360; 0.002),
even though adjusted for mean weighted IOP in the multivariate analysis. Lower target
pressures for older patients and patients with advanced glaucoma is thus supported.
The reversibility of ONH topography in ExG was studied (II, III) as well as the use of
scanning laser ophthalmoscopy (SLO) to detect progressive changes in the ONH (III). SLO
with the Heidelberg Retina Tomograph (HRT, Heidelberg Engineering GmbH, Heidelberg,
Germany) allows objective measurement of the optic nerve head (ONH) topography. This
method provides the examiner with a number of parameters describing the amount of nerve
fibres in the ONH. These parameters were tested in 80 patients with ExS and glaucoma (69
eyes) or ocular hypertension (11 eyes). Most HRT parameters were associated with the disc
area; the larger the disc, the more likely were these parameters to show values in the
direction of ‘more glaucomatous’. When the effect of disc area was taken into account, all
HRT parameters showed a statistically significant association with the amount of visual
field (VF) damage. This result supports the importance of adjusting for disc area when
HRT values are compared between different groups of patients.
The most advantageous application of SLO would be its use in follow-up of patients to aid
in detecting change or progression in ONH topography. In a prospective follow-up of 56
patients, change in VF index mean defect (MD) was shown to be associated with
subsequent change in one of the HRT parameters, the cup shape measure. This suggest that
cup shape measure may be a sensitive indicator for progression.
The reversal of ONH topography was studied in two sets of patients. HRT imaging was
performed before and after intervention in 10 eyes of 9 patients who underwent
trabeculectomy, and in 80 eyes (see above) treated with topical medication (13 eyes), argon
laser trabeculoplasty (42 eyes), or trabeculectomy (25 eyes). Decrease in IOP was
associated with reversal changes in most HRT parameters. Reversal changes could still be
detected one year after trabeculectomy, provided that the post-operative IOP was kept low
enough. It remains to be shown whether reversal of the ONH topography is related to
slower rate of progression of glaucoma, as has been suggested.
The concept of a vascular component in pathogenesis of ExG was evaluated by
measurements of ocular blood flow in eyes with ExOHT, ExG and ExS (IV, V). Ocular
blood flow was measured with two non-invasive techniques. Scanning laser Doppler
flowmetry (the Heidelberg Retina Flowmeter, HRF, Heidelberg Engineering GmbH) was
used to study ONH and peripapillary retinal blood flow in 50 patients with unilateral
ExOHT or ExG, and blue-field entoptoscopy to study macular capillary circulation in 10
patients with unilateral ExG and 11 patients with unilateral ExS. In the ONH, flow in the
rim area of the glaucomatous eyes was higher than in fellow eyes (P = 0.001), while the
difference in the lamina was of borderline significance (P = 0.065). However, results
indicated that more advanced glaucomatous damage, indicated by greater MD or smaller
rim volume, is associated with reduced flow both in the laminar area and in the rim area.
Also, treatment with topical timolol seemed to be associated with reduced flow in the
lamina and rim area. In the macula, leucocyte velocity (±SD) was significantly lower in
glaucomatous eyes (0.70 ± 0.25 mm/s) than in non-glaucomatous fellow eyes (0.89 ± 0.34
mm/s) (P = 0.02). In the glaucomatous eyes, correlation of borderline significance was
detected between leucocyte velocity and MD (r = -0.58, P = 0.08), and between leucocyte
velocity and loss variance (-0.62, 0.06). The results indicate that alterations in ocular blood
flow occur in ExG.
2. INTRODUCTION
Glaucoma is defined as a chronic progressive optic neuropathy independent of intraocular
pressure (IOP) level and without connection to any neurologic or other systemic disease.
Optic neuropathy is the common denominator in all types of glaucoma in which a
characteristic acquired loss of optic nerve fibres leads to loss of sight and ultimately
blindness. The current concept of glaucoma seems to be that there is a subgroup of patients
with glaucoma in which the disease is mainly dependent on IOP, and another subgroup in
which it is not (Schulzer et al. 1990). Exfoliation glaucoma (ExG) is considered a high-
pressure type of secondary glaucoma, in which high IOP leads to poor outcome if not
reduced. Therapy aims at lowering IOP to a level at which no further progression occurs
(= target pressure). In glaucoma, no other means or indicator exists than detection of
progression to determine whether IOP has been sufficiently reduced. Reversal of optic disc
cupping after reduction of IOP has been suggested to be such an indicator (Katz et al. 1989,
Tsai et al. 1991). In a recent series including eyes with ExG, the postoperative IOP level
after trabeculectomy was not associated with rate of visual field (VF) progression (Popovic
& Sjöstrand 1999), which suggests an influence on progression by factors other than IOP.
Many investigations have put forward evidence of vascular pathogenesis in ExG (Vannas
1969, Laatikainen 1971, Raitta & Vannas 1971, Vannas 1972, Pohjanpelto 1985, Sonnsjö
et al. 1988, Jonas et al. 1990, Cursiefen et al. 1997).
The clinical examination of the optic nerve head (ONH) includes a subjective component,
and detection of progressive ONH damage can be difficult. The importance of detecting
progression from the ONH is emphasized in early glaucoma, during which no VF defects
are yet detectable (Funk et al. 1988). Objective methods for ONH measurements have been
introduced to aid evaluation of ONH, but their clinical use in detecting progression is still
under investigation.
The present investigation on a hospital basis was begun to study the effect of IOP reduction
on risk for progression and factors affecting target pressure (I). The reversibility of ONH
topography in ExG was studied (II, III) as well as the use of scanning laser ophthalmoscopy
(SLO) to detect progressive changes in the ONH (III). The concept of a vascular
component in pathogenesis of ExG was evaluated by measurements of ocular blood flow in
eyes with ExG and exfoliation syndrome (ExS) (IV, V).
3. REVIEW OF THE LITERATURE
3.1 THEORIES OF GLAUCOMA
It seems that different mechanisms of damage occur in glaucoma. Schulzer et al. (1990)
identified two subgroups of glaucoma patients: one group in which the degree of VF
damage was correlated with IOP level, and one group in which it was not. In glaucoma,
ganglion-cell death can be mediated via apoptosis (Quigley et al. 1995). Mechanisms of
and stimuli leading to ganglion-cell death have recently been reviewed by Nickells (1996).
Stimuli that may lead to apoptotic cell death include neurotrophin deprivation and
glutamate toxicity (Nickells 1996). Neurotrophin withdrawal can be caused by blockage of
retrograde axonal transport during periods of increased IOP or by defective neurotrophin
transport by energy depletion due to ischaemia. Glutamate toxicity is believed to be caused
by ischaemia of the optic nerve and retinal ganglion-cells (Nickells 1996).
3.1.1 The mechanical theory
According to the mechanical theory of glaucoma, the main cause of glaucomatous ONH
damage is elevated IOP or increased susceptibility to IOP. Evidence exist that IOP
contributes to the pathogenesis of glaucoma. Elevated IOP and glaucomatous damage are
closely related (Armaly 1969, Armaly et al. 1980, Davanger et al. 1991b, Sommer et al.
1991b, Leske et al. 1995, Mitchell et al. 1996a), and glaucomatous damage can be
experimentally induced by increasing IOP (Quigley & Addicks 1980).
ExG is traditionally considered a secondary high-pressure glaucoma. The exact mechanism
of elevated IOP in ExS and ExG is controversial (Hansen & Sellevold 1970, Aasved 1971,
Layden & Shaffer 1974, Klemetti 1988, Puska & Raitta 1992, Gharagozloo et al. 1992), but
one widely accepted point of view is that the outflow capacity of aqueous humour is
reduced by mechanical obstruction of outflow by deposits of exfoliation material and
pigment in the trabecular meshwork (Madden & Crowley 1982, Wishart et al. 1985,
Rouhiainen & Teräsvirta 1991, Puska 1995, Schlötzer-Schrehardt & Naumann 1995,
Gottanka et al. 1997), by dysfunction of the trabecular cells, and by disorganization of
juxtacanalicular tissue and Schlemm’s canal (Schlötzer-Schrehardt & Naumann 1995).
Studies on aqueous humour dynamics have revealed higher resistance to outflow in eyes
with ExS than in their unaffected fellow eyes or control eyes (Pohjanpelto 1973, Layden &
Shaffer 1974, Johnson & Brubaker 1982, Gharagozloo et al. 1992). The exfoliation
material may be of both trabecular and exotrabecular origin (transported by the aqueous
humour to the trabecular area) (Ringvold & Vegge 1971, Morrison & Green 1988,
Schlötzer-Schrehardt & Naumann 1995, Gottanka et al. 1997), whereas pigment deposits
are probably liberated from the iris epithelium by mechanical scraping of the pupillary
border against the irregular lens surface (Krause et al. 1973, Layden & Shaffer 1974).
Exfoliation syndrome has also been associated with breakdown of the blood-aqueous
barrier in the iris and ciliary body and subsquent leakage of proteins into the aqueous
humour (Vannas 1972, Küchle et al. 1995, Küchle et al. 1996, Vesaluoma et al. 1998),
which may further increase outflow resistance.
A widely accepted view is that, in glaucoma, the site of initial damage to the ganglion-cell
axons is at the level of the lamina cribrosa (Gaasterland et al. 1978, Quigley et al. 1981).
The lamina cribrosa consists of approximately 10 lamellar sheets of connective tissue
which have pores that form channels for the ganglion-cell axons to pass through the sclera
(Quigley & Addicks 1981, Radius & Gonzales 1981). Increase in IOP may cause backward
bowing of the lamina cribrosa (Levy et al. 1981, Levy & Crapps 1984) with sliding of the
connective tissue layers in relation to each other, which leads to narrowing of laminar pores
(Quigley et al. 1981). This causes impingement of nerve fibres that run through the pores,
impeding orthograde and retrograde axoplasmatic transport in the neurons (Minckler et al.
1977, Gaasterland et al. 1978, Quigley & Addicks 1980) and leading subsequently to their
death. The pores at the superior and inferior poles of the lamina cribrosa are larger and the
lamellar sheets thinner than in the medial and lateral poles, offering less structural support
to the nerve fibres (Radius & Gonzales 1981, Quigley & Addicks 1981). The nerve fibres
that run through the pores at the superior and inferior poles may therefore be more
susceptible to mechanical damage (Quigley & Addicks 1980). These nerve fibres supply
the arcuate Bjerrum areas of the VF (Minckler 1980) which are known to be the
preferential site of VF damage in glaucoma. In studies on a biomechanical model of the
ONH, Bellezza et al. (2000) concluded that IOP-related stress within the load-bearing
connective tissues of the ONH is substantial even at low levels of IOP, and furthermore,
they found that peripapillary scleral stress was consistently highest near the superior and
inferior poles of the scleral canal.
However, it has been argued that the exfoliative process may be a risk factor for ONH
damage itself, independent of a raised IOP level. Davanger et al. (1991a) reported a higher
probability of glaucomatous damage at a certain IOP level in exfoliative eyes than in non-
exfoliative eyes, indicating increased vulnerability to increased IOP in exfoliative eyes.
Similarly, according to Ekström (1993), the presence of ExS increased the standardised
relative risk for glaucoma in eyes with ocular hypertension (OHT). In histological studies,
more severe elastosis of the lamina cribrosa has been found in ExG than in primary open-
angle glaucoma (POAG), and this has been suggested to be a contributing factor for
increased susceptibility to glaucomatous damage in eyes with ExG (Netland et al. 1995,
Pena et al. 1998).
Not all exfoliative eyes develop glaucoma (Hansen & Sellevold 1969, Henry et al. 1987,
Klemetti 1988). Henry et al. (1987) retrospectively followed non-glaucomatous eyes with
ExS (469 eyes of 347 patients). They reported the cumulative probability (±SD) of 5.3 ±
0.1% for elevated IOP (above 21 mmHg) at 5 years, and 15.4 ± 1.9% at 10 years. In her
study on 206 eyes with ExS, Klemetti (1988) reported that 71 eyes (34.5%) developed
OHT (IOP above 21 mmHg) or ExG during the 1 to 23 years of follow-up time. Why most
exfoliative eyes remain non-glaucomatous remains unknown. In their recent review, Vesti
& Kivelä (2000) postulated that one reason could be degeneration of the ciliary epithelium
in exfoliation syndrome and subsequent impaired aqueous secretion. Ultrastructural
changes in the ciliary epithelium in eyes with ExG (Lütjen-Drecoll et al. 1988) may indicate
malfunction of or damage to the ciliary epithelium. Johnson & Brubaker (1982) reported a
lower rate of aqueous humour flow in the anterior chamber in exfoliative eyes than in non-
exfoliative fellow eyes. However, in another fluorophotometric study, no difference was
found in aqueous humour flow rate between ExS and unaffected fellow eyes or control
eyes (Gharagozloo et al. 1992).
3.1.2 The vascular theory
Blood flow in a tissue is determined by perfusion pressure, i.e., arterial pressure minus
venous pressure, and resistance to flow between arteries and veins. Like other parts of the
central nervous system, the optic nerve and ONH exhibit autoregulation of blood flow
(Pillunat et al. 1997, Riva et al. 1997, Movaffaghy et al. 1998, Orgül et al. 1999). By
autoregulation, the resistance to flow is changed to keep blood flow constant despite
changes in the perfusion pressure, for example in cases of change in arterial pressure or
when venous pressure is altered by change in IOP. Ischaemia due to increased IOP may
result if autoregulation is impaired, for example because of innate deficiency or vasospasm.
There is evidence that in glaucoma autoregulation may be impaired (Grunwald et al. 1984,
Pillunat et al. 1985, Robert et al. 1989, Graham et al. 1995, Tielsch et al. 1995, Graham &
Drance 1999, Ghergel et al. 2000).
The role of systemic blood pressure is somewhat contradictive, as both hypertension
(Leighton & Phillips 1972, Wilson et al. 1987, Rouhiainen & Teräsvirta 1990b, Dielemans
et al. 1995) and hypotension (Richler et al. 1982, Peräsalo et al. 1992, Kaiser et al. 1993,
Graham et al. 1995, Graham & Drance 1999) have been shown to be associated with open-
angle glaucoma (OAG). In the Baltimore Eye Study (Tielsch et al. 1995), a trend toward a
protective effect was found for systemic hypertension in patients younger than 60 years of
age and an increased risk in patients older than 70. This was hypothesised to be caused by
increased blood flow early in the course of arterial hypertension (i.e., in younger patients),
but in more advanced disease (i.e., in older patients) the cause could have been reduced
blood flow due to damage to small vessels and increased resistance to flow. This could
explain the increased risk for POAG in the older patients with systemic hypertension
(Tielsch et al. 1995).
Ischaemia due to occlusion of small capillaries may also result from platelet or clotting
abnormalities. In the series by Schulzer et al. (1990), it was reported that in the presence of
clotting abnormalities, there were no relationship between the severity of glaucomatous
damage and IOP. Drance (1972) has reported disturbances in the coagulation-fibrinolytic
system in 61% of the glaucoma patients with IOP less than 22 mmHg, and O’Brien et al.
(1997) found elevated levels of prothrombin 1 + 2 fragments and D-dimer in untreated
POAG compared to normal tension glaucoma (NTG) and controls. This suggests that some
of the untreated POAG patients are in a hypercoagulable state which may contribute not
only to the pathogenesis of glaucoma, but also to the increased prevalence of venous
thrombosis in the glaucoma population (David et al. 1988, Mitchell et al. 1996b). ExS also
has been reported to be a risk factor for retinal vein thrombosis (Cursiefen et al. 1997), and
an association between vein occlusions and ExG has been suspected (Pohjanpelto 1985).
Disc haemorrhages have been shown to precede glaucomatous VF defects (Airaksinen et
al. 1981, Krakau 1983, Sonnsjö et al. 1988, Diehl et al. 1990, Bengtsson 1990) and to be
associated with progression of glaucomatous nerve fibre loss (Diehl et al. 1990, Ekström
1993, Siegner & Netland 1996). Disc haemorrhage seems to be as frequent in ExG as in
other types of glaucoma (Sonnsjö et al. 1988, Jonas et al. 1990). The aetiology of disc
haemorrhages is unknown. An ischaemic mechanism (Begg et al. 1971) as well as
mechanical trauma at the level of the lamina cribrosa (Quigley et al. 1981) have been
suggested. Sonnsjö & Krakau (1993) prospectively followed patients with glaucoma, disc
haemorrhages, or venous occlusion. During follow-up, patients with glaucoma developed
venous occlusions and disc haemorrhages, patients with venous occlusions developed
glaucoma and disc haemorrhages, and so on. They argued that disc haemorrhage, and
venous occlusion are two manifestations of the same disease appearing in different size
vessels and that the increase in IOP could be a late consequence of a vascular insult, i.e.,
thromboses of small venous capillaries in the retina and ONH leading to increased
intravenous pressure and subsequent increase in IOP.
Peripapillary atrophy has been extensively studied in glaucoma. Histologically, it represents
misalignment of the edges of the neural retina, retinal pigment epithelium, and the choroid
(Fantes & Anderson 1989). Peripapillary atrophy has been proposed as a sign of impaired
choroidal perfusion (Raitta & Sarmela 1970, Primrose 1971, Laatikainen 1971, Stewart et
al. 1995, Jonas & Hayreh 1999). Although the vasculatures of the peripapillary choroid and
anterior optic nerve are highly separated, they share a common arterial supply at the level of
the short posterior ciliary arteries, and the peripapillary choroid may also give off small
branches into the prelaminar and laminar regions of the ONH (Cioffi & Van Buskirk
1996). Several studies have shown peripapillary atrophy, specifically the zone beta atrophy,
to be associated with degree of glaucomatous ONH and VF damage (Raitta & Sarmela
1970, Wilensky & Kolker 1976, Hayakawa et al. 1998) as well as with progression of
glaucoma (Araie et al. 1994, Stewart et al. 1995, Park et al. 1996, Uchida et al. 1998,
Daugeliene et al. 1999, Jonas & Hayreh 1999). Hayakawa et al. (1998) also found an
association with frequency of disc haemorrhages. No difference in the size of the
peripapillary atrophy between ExG and POAG seems to exist (Jonas et al. 1990, Tezel &
Tezel 1993, Jonas & Papastathopoulos 1997). Puska & Raitta (1993) studied patients with
unilateral ExG. Although the areas of the peripapillary atrophy did not differ between
glaucomatous and their non-glaucomatous fellow eyes, a correlation between area of
peripapillary atrophy and extent of ONH damage appeared among glaucomatous eyes.
ExS seems to widely affect the ocular vasculature. Fluorescein angiographic studies of the
limbus (Laatikainen 1971, Raitta & Vannas 1971) and iris (Vannas 1969, Vannas 1972,
Parodi et al. 2000) have shown that ExS is associated with marked vascular changes.
Histological studies of the iris vessels in eyes with ExS have shown abnormal accumulation
of exfoliation material in the adventitia, degeneration of the cells of the vessel wall (smooth
muscle cells, pericytes, and endothelial cells), changes to the endothelial basement
membrane, and complete destruction or obliteration of the lumen (Ringvold 1970, Ringvold
& Davanger 1981, Konstas et al. 1993b, Asano et al. 1995, Kivelä et al. 1997). The iris
vasculopathy has been associated with anterior segment ischaemia (Vannas 1969, Vannas
1972, Helbig et al. 1994). Local hypoxia may contribute to degenerative tissue changes
(Asano et al. 1995) and neovascularisation (Ringvold & Davanger 1981) of the iris.
Exfoliation material has also been found electron microscopically in the posterior ciliary
arteries (Schlötzer-Schrehardt et al. 1991) (a finding not, however, confirmed
histochemically), which are the main supply to the ONH (Cioffi & Van Buskirk 1996).
Vasculopathy of these vessels may result in vascular insufficiency of the ONH blood
supply. In a prospective follow-up study on normotensive eyes with ExS (Puska et al.
1999), vascular change due to the exfoliative process was proposed as an explanation for
optic disc changes that developed during follow-up.
The presence of exfoliation material in visceral organs in patients with ocular ExS (Streeten
et al. 1992, Schlötzer-Schrehardt et al. 1992) may raise a question whether these systemic
effects associate ExS with systemic diseases, especially with systemic vascular disorders.
In a population-based screening study in Norway (Ringvold et al. 1991), the prevalence of
ExG increased with age, but declined in patients aged 80 years or older. This was
considered to be a sign of increased mortality associated with ExG. However, a later study
found no association between ExS and mortality rate (Ringvold et al. 1997). In a
population-based study in Australia (Mitchell et al. 1997), ExS was statistically
significantly associated with history of coronary disease or hypertension or a combined
history of coronary disease, acute myocardial infarction, or stroke. Repo et al. (1993) found
twice the prevalence of ExS among patients with transient ischaemic attack (TIA) as for the
general population of Finland; they concluded, however, that this finding supported
hypoperfusion as a contributory factor in the development of ExS. Shrum et al. (2000)
found no association between ExS and cardiovascular or cerebrovascular mortality. Nor has
any increased prevalence of ExS been found among patients operated on for abdominal
aortic aneurysm compared to that for the general population (Hietanen et al. 2000). As a
sign of altered cutaneous microcirculation, patients with ExG have been shown to have
lower cutaneous capillary flow than healthy volunteers or patients with POAG (Holló et al.
1998).
3.2 EXFOLIATION GLAUCOMA
3.2.1 Prevalence of ExS and ExG
ExG is defined as an open-angle glaucoma in eyes with ExS. A recent paper reviews the
prevalence of ExS in the world (Ringvold 1999). The prevalence of ExS seems to be
especially high in Finland and in Scandinavian countries (Forsius 1988). In population-
based studies in Finland, the following prevalences have been reported: 8.4% in patients
> 60 years old (Tampere) (Aine 1988), 8.5% in patients 65 years of age (Kuopio)
(Rouhiainen & Teräsvirta 1992), 21% in patients ≥ 65 (Kuusamo) (Krause et al. 1988),
13.2% in patients 75 (Kuopio) (Rouhiainen & Teräsvirta 1992), and 22.1% in patients ≥ 70
(Oulu) (Hirvelä et al. 1995). The prevalence of ExS seems clearly to increase with age
(Tarkkanen 1962).
Unilateral and bilateral ExS may represent different stages of the disease. Clinically
unilateral cases of ExS have been reported to convert into the bilateral form in 7 to 41% of
cases within 5 years (Hansen & Sellevold 1969, Henry et al. 1987, Klemetti 1988), and the
proportion of bilateral cases has been reported to increase with age (Tarkkanen 1962,
Rouhiainen & Teräsvirta 1992). Furthermore, in cases with unilateral ExS, exfoliation
material has been identified electron microscopically and immunohistochemically in the
clinically uninvolved eyes (Speakman & Ghosh 1976, Prince et al. 1987, Schlötzer-
Schrehardt et al. 1991, Kivelä et al. 1997).
In a population-based study in Finland (Oulu) among inhabitants ≥ 70 years old (Hirvelä et
al. 1994), the prevalence of ExG was 5.0% (25/500) and that for POAG was 5.4%. In a
study based on hospital records (Kotka) (Valle 1988), the prevalence of ExG was 0.26%
among all ophthalmological patients aged 55 to 64 years, 1.39% among patients aged 65 to
74 years, and 2.41% in patients aged 75 to 84 years. The corresponding prevalences for
POAG were 0.50%, 1.52%, and 2.06%, respectively. In Finland, the high prevalence of
ExG (and high proportion of ExG of all OAG) is probably associated with the high
prevalence of ExS (Ringvold 1999).
3.2.2 Clinical findings in the anterior chamber
The most typical sign of ExS is deposition of grayish-white material on the anterior lens
surface. Deposits can also be found on the pupillary border, iris surface, corneal
endothelium, lens zonules, and ciliary processess (Tarkkanen 1962, Morrison & Green
1988). Frequent findings are pigment dispersion and transillumination defects of the iris,
most prominent at the pupillary margin (Krause et al. 1973, Prince et al. 1987), as well as
heavy pigmentation of the anterior chamber angle (Wishart et al. 1985, Rouhiainen &
Teräsvirta 1990a, Puska 1995). In addition, high frequency of narrowness of the anterior
chamber angle has been reported, with 18% of cases having occludable angles in an
English material (Wishart et al. 1985).
3.2.3 IOP level
ExS is associated with increased IOP and constitutes a risk factor for glaucoma. The IOP in
the exfoliative eyes of unilateral cases has been shown to be higher than in their non-
exfoliative fellow eyes (Hansen & Sellevold 1970, Puska & Raitta 1992). Also in ExG,
IOP is typically higher than in POAG (Konstas et al. 1997a,b) and also shows greater
diurnal variation (Konstas et al. 1997b).
3.2.4 ONH morphometry
It has been claimed that the optic disc is smaller in ExG than in POAG and NTG. Jonas &
Papastathopoulos (1997) studied optic disc photographs of 99 patients with ExG, 658
patients with POAG, 42 patients with ExS, and 364 healthy controls. The disc area (± SD)
was statistically significantly smaller in ExG (2.52 ± 0.49 mm 2) than in POAG (2.71 ± 0.63
mm
2). Likewise, the disc area in eyes with ExS (2.48 ± 0.52 mm2) was less than in healthy
control eyes (2.67 ± 0.67 mm2). In another study, no differences in mean disc area were
found between ExG, POAG, and NTG, but small discs were more frequent in ExG and
large discs in NTG (Tuulonen & Airaksinen 1992). In a study of patients with unilateral
ExS, no difference in optic disc size was found between exfoliative and non-exfoliative
fellow eyes (Puska & Raitta 1992).
3.2.4.1 Covariation of ONH parameters with disc size
The ONH rim is formed by ganglion-cell axons as they pass through the scleral canal, with
most nerve fibres entering at the superior and inferior poles of the ONH. Therefore, the
retinal nerve fibre layer is thickest at the inferior and superior poles and thinner at the nasal
and temporal poles (Quigley & Addicks 1982); in the normal ONH, the rim is broadest
inferiorly, followed by the superior, nasal, and temporal regions, subsequently (‘the ISN’T
rule’) (Jonas et al. 1988b,c). As axons are lost in glaucoma, the amount of neural tissue in
the ONH rim decreases. Several parameters have been derived to describe the amount of
neural tissue in the ONH including rim area, cup area, cup/disc ratio, cup/disc area ratio,
cup volume, rim volumeand with introduction of SLOalso height variation contour,
mean and maximum cup depth, cup shape measure, mean retinal nerve fibre layer (RNFL)
thickness, and RNFL cross-section area. Numerous studies have shown significant
differences between normal and glaucomatous eyes in these ONH parameters (Airaksinen
et al. 1985, Caprioli & Miller 1988, Mikelberg et al. 1995, Uchida et al. 1996, Hatch et al.
1997, Bathija et al. 1998). However, there is marked interindividual variation in the ONH
size of the healthy population. (Jonas et al. 1988a,b, Jonas & Papastathopoulos 1997).
A larger disc would allow ganglion-cell axons to be spread within a larger area. Therefore,
there is also a physiological correlation between ONH area and ONH parameters
(Bengtsson 1976, Caprioli & Miller 1987, Britton et al. 1987, Jonas et al. 1988b,c, Garway-
Heath et al. 1998, Mardin & Horn 1998, Wollstein et al. 1998). Because of high
interindividual normal variation in ONH topography, marked overlap occurs between
normal and glaucomatous eyes in the ONH parameters, and no cut-off values have been
established for normal ONH parameters. Correction for optic disc size may improve the
diagnostic power of the ONH parameters (Jonas et al. 2000).
3.2.4.2 Glaucomatous RNFL damage
The RNFL can be visualised from stereophotographs or from red-free photographs and
with biomicroscopy using red-free light and high magnification. Changes in the RNFL have
been detected before changes in the ONH (Airaksinen & Alanko 1983) or VF (Sommer et
al. 1977, Quigley et al. 1994). However, when the RNFL has been semiquantatively
measured, a correlation has been found between RNFL damage and ONH rim area
(Airaksinen & Drance 1985).
In the series by Tuulonen & Airaksinen (1991), the initial glaucomatous RNFL damage was
reported to be diffuse atrophy in 52% (12/23 eyes), a wedge-shaped local defect in 30%
(7/23 eyes), and a combination of these in 17% (4/23 eyes). The proportion of exfoliative
eyes was found to be small in the group with localised damage, but this finding did not
reach statistical significance. Localised optic disc and RNFL changes were located in the
upper and lower temporal regions. No localised changes were found in the nasal or
papillomacular regions. A method recently developed uses scanning laser polarimetry for
quantitative measurement of the RNFL (Weinreb et al. 1990), and differences in RNFL
thickness between glaucomatous and healthy eyes have been detected (Weinreb et al. 1998,
Lee & Mok 1999, Sinai et al. 2000).
3.2.4.3 Glaucomatous ONH damage
Glaucomatous damage in the ONH appear before damage in the VF (Jonas & Gründler
1997). Great variability in the appearance of early glaucomatous ONH damage seems to
exist. A local rim notch is a classical finding in glaucoma and clinically may be detected
more easily than general cup enlargement. However, general enlargement of the cup has
been reported as the most common form of initial damage (Pederson & Anderson 1980,
Tuulonen & Airaksinen 1991). The latter group followed 61 eyes with OHT (also including
exfoliative eyes), of whom 23 developed glaucoma during the study. Corresponding optic
disc changes included diffuse cup enlargement (10 eyes, 43%), local notching (6 eyes,
26%), diffuse cup enlargement with local notching (4 eyes, 17%), and the neuroretinal
rim’s turning pale with no change in configuration of the cup (3 eyes, 13%). The proportion
of exfoliative eyes in the group with localised damage was small, but the finding did not
reach statistical signficance. Linnér et al. (1989) studied disc pallor in eyes with OHT and
found it to be more pronounced among exfoliative than non-exfoliative eyes.
In a cross-sectional study, Jonas et al. (1993) studied optic disc photographs of 801
glaucomatous and 496 healthy eyes. In all stages of glaucoma, rim loss could be found in
all sectors, but with a preferential rim loss in the temporal inferior sector, followed
subsequently by the temporal superior, temporal horizontal, nasal inferior, and nasal
superior sectors. The results for ExG were not separately reported. Recent work in
differentiating between glaucomatous and non-glaucomatous eyes has emphasized rim
damage at the disc poles (Gundersen et al. 1996, Iester et al. 1997e, Iester et al. 1998,
Gundersen et al. 1999). The studies by Gundersen et al. (1996, 1999) included eyes with
ExG, POAG, and NTG; ONH damage was most pronounced at the poles.
The temporal inferior and temporal superior sectors also seem to be the most common
sectors in which notching occurs (Jonas et al. 1988c, Tuulonen & Airaksinen 1991). A
connection between localised notching and optic disc haemorrhage has been suggested,
optic disc haemorrhage has been reported to be more frequent in eyes with localised
notching than in eyes with generalised enlargement of the cup (Tuulonen & Airaksinen
1991, Nicolela & Drance 1996). In addition, disc haemorrhage may predict the location of
future rim and RNFL damage (Airaksinen et al. 1981, Tuulonen et al. 1987).
It has been proposed that type of cupping is dependent on IOP: local notching may occur at
lower IOP levels and diffuse cupping at higher IOP levels (Shiose et al. 1987, Nicolela &
Drance 1996, Eid et al. 1997a). Local damage has, however, been found in eyes with
elevated IOP, as well (Pederson & Anderson 1980, Tuulonen & Airaksinen 1991, Iester et
al. 1998). Some controversy exists on the type of damage that occurs in ExG. Tezel &
Tezel (1993) found only diffuse loss of the rim in ExG without the sectoral preference they
found in the eyes with POAG. However, Jonas et al. (1990) found no difference between
ExG and POAG in the proportions of localised and diffuse defects of the RNFL, nor in the
location of the thinnest part of the neuroretinal rim.
3.2.4.4 Reversibility of ONH topography
ONH topography can change in relation to changes in IOP. In experimental studies on
enucleated primate and human eyes, Levy et al. (1981) and Levy & Crapps (1984)
examined radiographically the position of a platinum wire placed in the lamina cribrosa and
demonstrated the retrodisplacement of the lamina cribrosa after increasing IOP. Coleman et
al. (1991) demonstrated the retrodisplacement of the ONH surface after experimental
increase in IOP. Reversal of the disc cupping or ONH topography refers to a change in the
less ‘glaucomatous’ direction (decrease in cup volume or cup area, increase in rim volume,
rim area, or in other parameters describing the amount of neural tissue in the ONH). In
experimental and clinical studies with humans and primates, reversal of cupping and ONH
topography has been documented in glaucomatous eyes after reduction in IOP by use of
stereophotography, computerized image analysis, or SLO (Pederson & Herschler 1982,
Katz et al. 1989, Shin et al. 1989, Tsai et al. 1991, Shirakashi et al. 1992, Sogano et al.
1993, Chavis et al. 1994, Irak et al. 1996, Park & Hong 1998, Topouzis et al. 1999, Lesk et
al. 1999). The physiological basis for reversal of ONH topography is unknown, but reduced
backward bowing of the lamina seems most likely (Pederson & Herschler 1982, Lusky et
al. 1993b, Sogano et al. 1993). The amount of reversal has been shown to correlate with
degree of IOP reduction (Shin et al. 1989, Sogano et al. 1993, Lesk et al. 1999, Irak et al.
1996).
Reversibility has been claimed to be dependent on degree of glaucomatous damage. In
studies on experimental primate glaucoma (Coleman et al. 1991, Shirakashi et al. 1992),
degree of reversal of optic disc cupping has been decreased in those eyes with advanced
glaucomatous damage. In humans, as well, (Pederson & Herschler 1982, Quigley 1982),
reversal of disc cupping has been apparent in eyes with damage at an early stage, but not in
eyes with advanced glaucoma. In human eyes post-mortem, less retrodisplacement of the
ONH occurs in relation to the surrounding sclera, as the VF worsens (Zeimer & Ogura
1989). Age may also affect reversibility. In adults, reversal in older patients has been
reported to be greater than in younger ones (Lesk et al. 1999). However, reversal of
cupping is also a frequent finding after successful IOP reduction in childhood glaucoma
(Quigley 1982).
3.2.5 VF damage
The VF defect in glaucoma can be diffuse and localised (Mikelberg & Drance 1996).
Diffuse damage can be seen as isopter contraction in kinetic perimetry or generalised
depression of retinal sensitivity in automated static perimetry (Hart & Becker 1982, Cyrlin
1996). Typical focal defects include nasal step, isolated arcuate scotoma separated from the
blind spot, arcuate blind spot enlargement, and paracentral scotoma (Hart & Becker 1982,
Cyrlin 1996). In very advanced glaucoma, usually the only remaining areas in the VF are
central and temporal islands (Cyrlin 1996). No difference seems to exist in the pattern of
VF defects between ExG and POAG (Lewis & Phelps 1984). Lewis & Phelps (1984)
studied VF defects in 224 eyes of 148 patients with POAG and 74 eyes of 63 patients with
secondary glaucoma (30% had ExG); similar VF defect patterns were noted for POAG and
the secondary glaucomas.
A topographical relationship exists between VF and optic disc damage (Weber et al. 1990,
Eid et al. 1997b, Yamagishi et al. 1997). In eyes with local ONH damage, localised VF
defects can usually be detected (Nicolela & Drance 1996); however, those eyes with
localised glaucomatous VF loss may have observable optic disc damage of either local or
diffuse nature (Emdadi et al. 1998).
3.2.5.1 Reversal of VF damage
Evidence exist of improvement in glaucomatous VF damage after IOP reduction (Katz et
al. 1989, Tsai et al. 1991, Rolando et al. 1993). Some degree of association has also been
detected between improvement in VF and reversal of optic disc topography (Katz et al.
1989, Tsai et al. 1991). Tsai et al. (1991) studied 28 eyes of 28 patients in whom had been
detected reversal of disc cupping. Improvement in the mean VF global indices occurred in
eyes with IOP reduction of more than 40% in contrast to no improvement in eyes with less
than 35% IOP reduction.
A learning effect also appears in VF testing; patients inexperienced with perimetry testing
may show some improvement between the first few examinations (Heijl & Bengtsson
1996).
3.3 PROGRESSION OF ExG
ExG is known to show more aggressive clinical course than POAG (Konstas et al. 1997c,
Olivius & Thorburn 1978). According to Thorburn (1988), 2.5% of all the individuals in
one defined population developed VF defects due to ExG within their lifetime. If
glaucomatous cupping without VF defects was present at diagnosis, 50% developed VF
defects within their lifetime, and of those with a moderate VF defect at diagnosis, 59% had,
within their lifetimes, progression into another stage. In other studies, the outcome of ExG
and of POAG has been compared; in general, a worse prognosis can be expected in ExG
than in POAG (Olivius & Thorburn 1978, Pohjanpelto 1985).
Differing patterns have been reported in progression of glaucomatous ONH and VF defect:
a linear pattern with a constant rate of progression, an episodic pattern with bursts of faster
progression periods, and a curvlinear pattern with either faster progression early in follow-
up and a slower progression rate later, or slower progression early and an increase in
progression rate later (Mikelberg et al. 1986, Airaksinen et al. 1992). Airaksinen et al.
(1992) studied ONH rim area and found a linear type of progression in approximately half
the patients, an episodic in one-fifth, and a curvlinear type in one-third. No differences in
patterns of progression occurred between ExG, POAG, and NTG. Mikelberg et al. (1986)
studied VFs of patients with chronic OAG and IOP above 21 mmHg. Of the eyes that
progressed (34 eyes), 65% showed linear, 26% curvlinear, and 9% episodic progression.
The results for ExG were not separately reported.
3.3.1 Definition and detection
Progression of glaucoma can be defined as an increase either in the glaucomatous ONH
damage or in VF defect. Because of overlapping of the receptive fields of the ganglion
cells, 20 to 40% of nerve fibres can be lost before defects appear in the VF (Quigley et al.
1989). Thus, progressive RNFL (Airaksinen & Heijl 1983, Sommer et al. 1991a, Tuulonen
et al. 1993, Quigley et al. 1994) and ONH damage (Pederson & Anderson 1980, Odberg &
Riise 1985, Pohjanpelto 1985, Zeyen & Caprioli 1993, Jonas & Gründler 1997) can usually
be detected prior to VF loss. However, new perimetry techniques for assessing early
glaucomatous damage, such as blue-on-yellow perimetry and high-pass resolution
perimetry, may be superior to conventional perimetry (Martinez et al. 1995, Teesalu et al.
1997, Teesalu et al. 1998, Chauhan et al. 1999). On the other hand, in more advanced
glaucoma with definite VF defects, detection of progression is more likely from the VF
than from the ONH (Funk et al. 1988); a small further loss in ganglion-cell number affects
visual function but is not easily detected in ONH morphology.
Determination of ONH progression is often based on subjective evaluation of the ONH:
general enlargement of the cup, enlargement of a notch, or appearance of a new notch. No
quantitative cut-off values have been established to tell how much change is indicative of
progression. Kamal et al. (2000) compared change over time in parameters of the
Heidelberg Retina Tomograph (HRT, Heidelberg Engineering GmbH, Heidelberg,
Germany) for healthy eyes and eyes with OHT. A subset of eyes with OHT showed change
in the HRT parameters above the expected level for normal variability in a ‘more
glaucomatous’ direction. A forthcoming report on whether these OHT patients will have a
higher incidence of glaucoma than those without similar changes in the ONH, is awaited.
The detection of VF progression is a complex problem, and many statistical methods have
been developed for this purpose. Because the VFs of healthy individuals and glaucoma
patients are subject to both intra-test fluctuation (short-term fluctuation) and inter-test
fluctuation (long-term fluctuation) (Heijl et al. 1987), detection of progression requires
multiple VF examinations to differentiate between progression and fluctuation (Heijl et al.
1989). The VF defect can progress as an increase in size and depth of a scotoma, as
appearance of a new scotoma, or as generalised loss of retinal sensitivity (Mikelberg &
Drance 1996). Several definitions of progression have been in use. In some studies using
kinetic perimetry, patients have been divided into different stages according to the degree
and appearance of ONH and VF damage, and subsequently, progression has been defined
as entering another stage (Thorburn 1988, Törnqvist & Drolsum 1991). In automated
perimetry, definition of progression can be based on number and depth of adjacent test-
points with reduced sensitivity relative to normative data. Several different criteria for
progression have been introduced, such as the one in the Glaucoma Laser Trial study (The
Glaucoma Laser Trial research group 1991), and the more complex scoring systems used
by the Advanced Glaucoma Intervention Study (The Advanced Glaucoma Intervention
Study investigators 1994) and the Collaborative Initial Glaucoma Treatment Trial (Musch
et al. 1999).
3.3.2 Risk factors for progression
3.3.2.1 IOP level
Numerous reports show that a wide consensus exists as to the association of elevated IOP
and increased risk for progression of glaucoma. Studies of patients with OHT have shown
that the higher the IOP, the higher the incidence of conversion into glaucoma (Kass et al.
1980, Pohjanpelto 1986, Quigley et al. 1994). The rate of progression of glaucoma
increases with IOP (Kolker 1977, Shirakashi et al. 1993, Jay & Murdoch 1993, Chihara et
al. 1997, Suzuki et al. 1999); moreover, rate of progression decreases in correlation with
amount of IOP reduction (Vogel et al. 1990, Migdal et al. 1994).
Studies of exfoliative eyes have shown this to be true also in ExS and ExG. Among
exfoliative eyes with OHT, lower IOP has been associated with decreased risk for
glaucomatous damage (Pohjanpelto & Palva 1974, Pohjanpelto 1986). In newly diagnosed
ExG, a significant relationship has been reported between presenting (untreated) IOP level
and VF damage (Teus et al. 1998). However, in a retrospective study by Pohjanpelto
(1985), no significant differences existed in the mean IOP of eyes with ExG and stable VFs
compared to those with VF progression. It has been claimed that in cases with a similar IOP
level, the optic disc in ExG may be more vulnerable to glaucomatous damage than in
POAG (Pohjanpelto & Palva 1974, Davanger et al. 1991a, Teus et al. 1998).
Despite intensive treatment and good control of IOP, some eyes with ExG continue to
progress. Popovic & Sjöstrand (1999) studied the outcome of high-resolution perimetry in
eyes with ExG and POAG after trabeculectomy. They reported similar mean IOP (about 16
mmHg) both in eyes with progressive and non-progressive VFs, and an IOP level unrelated
to rate of VF progression. This may support the theory that other factors than IOP are
involved in the pathogenesis of both POAG and ExG.
3.3.2.2 IOP variation
Not only mean IOP level, but also variation in IOP should be considered in glaucoma. IOP
shows diurnal variation both in healthy and glaucomatous eyes (Drance 1960, de Venecia
& Davis 2000), but the variation in glaucomatous eyes has been shown to be greater than in
healthy eyes (Drance 1960, David et al. 1992). When different types of glaucoma are
compared, the diurnal variation in eyes with ExG has been reported to be greater than in
POAG (Jonas & Papastathopoulos 1997, Konstas et al. 1997b). Variation in diurnal IOP
has been identified as a risk factor for progression. Diurnal IOP variation has been reported
to be greater in eyes with OHT that later developed glaucoma than in those that remained
OHT (Odberg & Riise 1987). Among patients with ExG (Bergeå et al. 1999) and POAG
(Stewart et al. 1993, Bergeå et al. 1999, Asrani et al. 2000), smaller IOP variation has been
associated with better VF prognosis. In a prospective study on eyes with POAG, peak IOP
but not mean IOP differentiated between those who had progressive VF defects in high
resolution perimetry and those who remained stable (Martínez-Belló et al. 2000).
3.3.2.3 Age
All large population-based cross-sectional surveys report an increasing prevalence of OAG
(POAG, NTG and ExG) with increasing age (Hollows & Graham 1966, Leibowitz et al.
1980, Bengtsson 1981, Mason et al. 1989, Ringvold et al. 1991, Klein et al. 1992, Coffey et
al. 1993, Leske et al. 1994, Dielemans et al. 1994, Mitchell et al. 1996a, Kozobolis et al.
2000). Age has also been a risk factor for conversion of OHT to POAG (Quigley et al.
1994, Georgopoulos et al. 1997, Martínez-Belló et al. 2000). In a large 13-year prospective
follow-up study of 5000 subjects by Armaly et al. (1980), age was one of the risk factors
for glaucomatous VF defect. On the other hand, other follow-up studies have found no
effect of age (Wilson et al. 1982, Chihara et al. 1997). In his recent review of the role of
age and cardiovascular disease in glaucoma, Hayreh (1999) concludes that the influence of
age may be an indirect one, representing the higher prevalence and duration of
cardiovascular disease in the elderly population, rather than age, per se. In healthy eyes, the
nerve-fibre count of the optic nerve is known to decrease with age (Balazsi et al. 1984,
Jonas et al. 1992), which may make the nerve susceptible to any damage caused by
glaucoma.
3.3.2.4 Previous damage
In clinical practice it is generally agreed that eyes with far-advanced glaucoma, being more
susceptible to further VF damage than are eyes with early damage, require lower IOPs in
order to remain non-progressive (Olivius & Thorburn 1978, Wilson et al. 1982, Anderson
1989, Shirakashi et al. 1993, Stewart et al. 1993, Martínez-Belló et al. 2000). This finding
may be connected with disruption of the structure of the lamina cribrosa and a decrease in
collagen density, resulting in less structural support (Quigley et al. 1991).
3.3.2.5 Disc area
It has been hypothesised that large discs have the biomechanical disadvantage of offering
less structural support at the level of the lamina cribrosa than do small discs (Chi et al.
1989), and thus eyes with larger discs may be more vulnerable to IOP (Tuulonen &
Airaksinen 1992, Burk et al. 1992, Tomita et al. 1994).
Heijl & Mölder (1993) showed that disc area affects the probability of detecting glaucoma.
Larger discs were more likely to be classified as glaucomatous (whether glaucomatous or
not), and smaller discs were more likely to be classified as normal. Consequently, patients
with larger discs are more likely to attract clinical attention. Thus, any clinic-based study
offers the danger of selection bias, and any effect of disc area on risk for glaucoma or its
progression may easily be overestimated. Quigley et al. (1999) reported on data from the
population-based Baltimore Eye Survey. After adjustment for age, race, and gender in a
regression model, eyes with OAG tended to have slightly larger discs than the controls, but
only at borderline statistical significance (P = 0.06). Data from the population-based Blue
Mountains Eye Study (Healey & Mitchell 1999) showed statistically significantly greater
optic disc diameters in glaucomatous eyes (1.556 mm) than in non-glaucomatous eyes
(1.506 mm), eyes with OHT (1.494 mm), or eyes with ExS (1.501 mm).
3.4 TREATMENT OF ExG
3.4.1 To influence IOP
Irrespective of the pathogenesis of glaucoma, IOP remains the only risk factor to be
affected. Despite extensive studies on glaucoma, no safe IOP level has been identified for
any type of glaucoma (Jampel 1997). More likely, the target pressures have to be set
individually and in relation to IOP as well as to other risk factors. It has been hypothesised
that the effect of IOP reduction may be mediated through reduction in backward bowing of
the lamina and reduced mechanical stress to the ganglion-cell axons, which may improve
axoplasmic flow and reduce possible hypoxia (Shin et al. 1989). IOP reduction also
increases ocular perfusion pressure (Hayreh 1994), a reduction which may improve ocular
blood flow in cases of impaired autoregulation of blood flow, as has been suggested to
occur in glaucoma (Pillunat et al. 1985, Robert et al. 1989, Tielsch et al. 1995).
Some differences in success rates for various treatment modalities seem to exist between
ExG and POAG. Medical treatment fails more often in ExG than in POAG (Olivius &
Thorburn 1978, Blika & Saunte 1982, Pohjanpelto 1985), and more often a combination of
drugs is required (Airaksinen 1979, Konstas et al. 1998). As hypothesised by Konstas &
Diafas (1999), miotics may play a special role in the treatment of ExG, reducing
mechanical scraping of the iris against the lens surface, which results in less deliberation of
pigment and exfoliation material.
Argon laser trabeculoplasty (ALT) (Wise & Witter 1979) seems to result in a better initial
response in ExG than in POAG (Pohjanpelto 1983, Bergeå 1986, Bergeå & Svedbergh
1992, Threlkeld et al. 1996). Late response results are somewhat more controversial.
Bergeå (1986) reported a higher proportion of eyes with ExG than with POAG which
showed successful ALT after 2 years, and greater mean IOP reduction has been reported in
ExG than in POAG 1 to 5 years after ALT (Tuulonen & Airaksinen 1983, Rouhiainen et al.
1995), but the resulting mean IOP level may be similar (Bergeå et al. 1994). Threlkend et
al. (1996) reported the long-term IOP-reducing effect of ALT to be similar in ExG and
POAG. A more favourable outcome in terms of ONH and VF progression in ExG than in
POAG after primary ALT has been reported (Bergeå et al. 1995a,b).
Trabeculectomy is more effective than ALT or medical treatment for reduction in IOP
(Migdal et al. 1987, Migdal et al. 1994) and may also result in less IOP variation (Migdal et
al. 1994). ExG responds well to trabeculectomy (Jerndal & Kriisa 1974, Raitta & Vesti
1991), and the response is equal to (Popovic & Sjöstrand 1999) or better than (Törnqvist &
Drolsum 1991, Konstas et al. 1993a, Tanihara et al. 1993) in POAG. Popovic & Sjöstrand
(1999) prospectively followed eyes with ExG and POAG after trabeculectomy. Medical
treatment had to be reinstated at a similar rate in both types of glaucoma; however, the IOP
level in eyes without post-operative glaucoma medication was lower in those eyes with
ExG. No difference between the groups appeared in the post-operative rate of VF
deterioration. On the other hand, Tanihara et al. (1993) reported a better overall success
probability (lower post-operative than pre-operative IOP, no VF or disc deterioration, and
no need for further IOP-lowering surgery) in eyes with ExG (73.5 ± 6.3%) after 5 years
when compared to eyes with POAG (58.0 ± 3.1%). Similarly, Törnqvist & Drolsum (1991)
reported that eyes with ExG experienced less progression (optic disc or VF) after
trabeculectomy than did eyes with POAG, and Konstas et al. (1993a) reported lower post-
operative IOP in eyes with ExG than in eyes with POAG.
It has been suggested that early or even primary trabeculectomy would result in better
prognosis than trabeculectomy after a period of unsuccessful medical treatment (Jay &
Murray 1988). In that prospective, randomised study on glaucomatous eyes with IOP ≥ 26
mmHg (including eyes with ExG), they compared treatment with primary trabeculectomy to
trabeculectomy after unsuccessful medical treatment. Trabeculectomy was equally effective
in both groups of patients in respect to IOP reduction, but less progression of VF occurred
in the primary trabeculectomy group, a difference they theorised may have been caused by
progression in the medically treated group during the period before trabeculectomy.
Trans-scleral cyclodestructive techniques have usually been limited to eyes with refractory
glaucoma with unsuccessful filtration surgery or with an estimated poor response to
filtration surgery (Wesley & Kielar 1980, Hampton et al. 1990, Vesti et al. 1992, Immonen
et al. 1994, Spencer & Vernon 1999). Aqueous drainage implants, such as the Molteno
implant, are also available for these patients (Mills et al. 1996, Välimäki et al. 1998).
Trabecular aspiration has been introduced as a new form of treatment in ExG (Jacobi &
Krieglstein 1995). Trabecular debris and pigment are cleared from the trabecular meshwork
with an aspiration probe. An IOP reduction of approximately 30% has been achieved in
some patients (Jacobi et al. 1998), and a successful IOP reduction 2 years after therapy with
combined phacoemulsification and IOL implantation and trabecular aspiration in 64% of
the eyes has been reported (Jacobi et al. 1999).
3.4.2 Ocular blood flow and neuroprotection
As there seems to be an association between glaucoma and impaired ocular blood flow, the
issue of treatment of glaucoma by improvement of ocular blood flow seems logical. Many
studies concern the use of various calcium-channel blockers, especially in NTG. Several
investigators have reported calcium-channel blockers to be associated with a reduced
progression rate of VF in NTG (Kitazawa et al. 1989, Netland et al. 1993, Sawada et al.
1996, Daugeliene et al. 1999) and even with improvement in VF and colour vision after
their administration (Piltz et al. 1998). Some controversy, however, exists (Liu et al. 1996).
Evidence exists that treatment with oral calcium-channel blockers reduces the vascular
resistance of the retrobulbar arteries (Yamamoto et al. 1998). Results have not been
consistent (Wilson et al. 1997). Harris et al. (1997) and Cellini et al. (1997) were able to
link improved perfusion after oral administration of calcium-channel blockers with
improved visual function; improved perfusion in the retrobulbar arteries was associated
with improved contrast sensitivity (Harris et al. 1997) and improved VF indices (Cellini et
al. 1997). It remains unknown whether any possible effect of calcium-channel blockers on
progression is mediated through vasodilation and improved perfusion, or whether they act
directly on the calcium metabolism involved in cell death (Osborne et al. 1999).
It has also been suggested that the carbonic anhydrase inhibitor dorzolamide may improve
ocular haemodynamics (Martinez et al. 1999). Harris et al. (1999) detected improved
contrast sensitivity, reduced IOP, and shortened retinal arteriovenous time after treatment
with dorzolamide in patients with NTG. However, there was no correlation on an individual
basis between improved contrast sensitivity and reduced IOP or shortened retinal
arteriovenous time.
Not without some controversy (Drance 1997), betaxolol has been suggested to have a better
effect on halting VF progression than does timolol (Messmer et al. 1991, Kaiser et al. 1992,
Flammer et al. 1993, Tasindi & Talu 1997), although timolol reduces IOP more effectively
(Kaiser et al. 1992, Flammer et al. 1993). The more favourable outcome with betaxolol may
be due to a vasorelaxant (Harris et al. 1995, Hesse 1995) or a neuroprotective (Osborne et
al. 1997) effect. Possible neuroprotective strategies in glaucoma have recently been
reviewed by Osborne et al. (1999).
4. AIMS OF THE STUDY
To evaluate, among referred patients in a hospital setting, the risk factors for conversion of
ocular hypertension with exfoliation syndrome to exfoliation glaucoma and progression of
exfoliation glaucoma (I)
To create a formula suitable for clinical use to describe IOP level over time (I)
To evaluate, after IOP-lowering therapy, the reversibility of glaucomatous optic nerve head
changes by scanning laser ophthalmoscopy (II,III)
To find the most suitable Heidelberg Retina Tomograph parameter to detect progression
(III)
To evaluate optic nerve head blood flow and correlate it with degree of glaucomatous optic
nerve head and visual field damage (IV)
To test macular and peripapillary retinal circulation in exfoliation syndrome, exfoliation
syndrome with ocular hypertension, and exfoliation glaucoma (IV,V)
5. PATIENTS AND METHODS
5.1 DEFINITIONS
Glaucomatous optic disc damage = General enlargement of the cup/disc ratio and/or a local
notching of the rim.
Glaucomatous VF = VF measured with the Octopus perimeter (Interzeag, Schlieren,
Switzerland) using program G1 with 1) ≥ 3 adjacent test points of ≥ 5 dB loss, 2)
≥ 2 adjacent points of ≥ 10 dB loss, or 3) difference of ≥ 10 dB across nasal the
horizontal meridian at ≥ 2 adjacent points (Caprioli 1991). By Goldmann’s kinetic
perimetry, arcuate scotomas within 30°, paracentral scotomas, nasal steps, sector-
shaped defects in the periphery, and isopter contractions were considered
glaucomatous.
5.2 STUDY DESIGN
Study I was retrospective, in which data on IOP levels and VFs was collected from patient
charts, as well as from a control visit to which the patients were invited (Table 1). Study II
was a prospective follow-up study, in which HRT imaging was performed once before and
twice after trabeculectomy. In the cross-sectional part of Study III, HRT parameters were
compared to VF indices, and in the prospective follow-up part of Study III, ONH
topography was studied at 6-month intervals for up to 2 years after treatment with
medication, ALT, or trabeculectomy. Studies IV and V were cross-sectional, in which
ocular blood flow was studied in patients with unilateral ExG and ExS.
Table 1. Characteristics of patients and eyes included in the studies
Study I II III IV V
Study type Retrospective
follow-up
Prospective
follow-up
Cross-sectional and
prospective follow-up
Cross-sectional Cross-sectional
Number of
eyes/patients
139 / 139 10 / 9 80 / 80 100 / 50 42 / 21
Mean age (±SD)
(range)
69.9 ± 7.7
(50-88)
65.6 ± 8.1
(55-75)
68 ± 7
(50-83)
67.8 ± 7.4
(51-85)
62.9 ± 7.9
(50-74)
Diagnosis
 Study eyes ExOHT (n = 34)
ExG (n = 105)
ExG (n = 6)
POAG (n = 3)
NTG (n = 1)
ExOHT (n = 11)
ExG (n = 69)
ExOHT (n = 10)
ExG (n = 40)
ExS (n = 11)
ExG (n = 10)
Fellow eyes ExS (n = 36)
Non-ExS (n = 14)
Non-ExS (n = 21)
Main outcome
measures
Mean weighted IOP
Progression of
glaucoma
Diurnal IOP
ONH topography
(scanning laser
ophthalmoscopy)
Diurnal IOP
ONH topography
(scanning laser
ophthalmoscopy)
ONH and
peripapillary blood
flow (scanning laser
Doppler flowmetry)
Macular capillary
circulation (blue-
field entoptoscopy)
ExS = exfoliation syndrome, ExG = exfoliation glaucoma, ExOHT = Exfoliation syndrome with ocular hypertension, IOP = intraocular pressure,
N = number of eyes, NTG = normal tension glaucoma, ONH = optic nerve head, POAG = primary open-angle glaucoma
5.3 PATIENTS
The study was performed in the Helsinki University Eye Hospital (HUEH). The procedures
followed the tenets of the Declaration of Helsinki and were approved by the Department of
Ophthalmology’s Ethics Committee. Informed consent was obtained from all patients. The
study included a total of 249 patients: 235 with ExOHT or ExG, 11 with unilateral ExS,
two with POAG, and one with NTG (Table 1). Four of the patients with ExG in Study I
also participated in Study II, 36 of the patients in Study III also participated in Study IV.
All the 10 patients with ExG in Study V also participated in Study III, and 7 also in Study
IV. In Study IV, 50 fellow eyes (36 with and 14 without ExS), and in Study V, 21 fellow
eyes (all non-exfoliative) were also studied.
5.4 METHODS FOR EXAMINING THE EYE
5.4.1 Clinical examination
Clinical examination included measurement of visual acuity, IOP measurement,
biomicroscopic examination, and gonioscopy if not previously performed. For pupillary
dilatation, 0.5% tropicamide and 2.5% metaoxedrine were instilled. The optic discs were
examined with the Volk 90 D lens and/or evaluated from stereophotographs.
5.4.2 IOP
All IOP values were obtained with a Goldmann applanation tonometer. To obtain diurnal
IOP curves, IOP was measured at 7.30, 11.30, and 14.30. If the patient was using topical
glaucoma medication, the first drop of the day was applied after the IOP measurement at
7.30.
5.4.3 Visual field examinations
VFs were taken with the Octopus perimeter program G1, and only fields with less than
25% false-negative and false-positive answers were accepted in the analyses. If the patient
was unable to perform reliable automated perimetry, Goldmann kinetic perimetry was
performed.
5.4.4 Grading of glaucoma
Glaucoma was graded according to a system modified from that used by Thorburn (1988);
he included only eyes with IOP exceeding 30 mmHg (with normal VF and without glauco-
matous cupping) in Stage 1:
Stage 1: OHT = elevated IOP exceeding 24 mmHg on at least two occasions, or one
single measurement of 30 mmHg or more with a normal VF and without
glaucomatous cupping of the optic disc.
Stage 2: Glaucomatous disc cupping with normal VF.
Stage 3: Glaucomatous disc cupping and one scotoma within 30°, and/or a nasal step or
a sector-shaped defect in the periphery.
Stage 4: As in Stage 3, but with the addition of a new scotoma within 30° in the
opposite half of the VF, or the creation of a breakthrough to the periphery.
Stage 5: As in Stage 4, with the addition of a breakthrough to the periphery both
upwards and downwards from the paracentral scotoma.
Stage 6: A small remnant of the central VF and a temporal remnant.
Stage 7: A temporal remnant; loss of central VF (visual acuity 0.1 or less)
The grading of all eyes with glaucoma or OHT is shown in Table 2. In Study II, the stage of
glaucoma was also graded as moderate (arcuate scotoma) or severe (ring-shaped scotoma or
only a temporal field).
5.4.5 Measurement of ONH topography
SLO imaging was performed with the HRT. Software version 1.11 was used in Study II
and version 2.01 in Studies III and IV. Three topographic images were obtained with the
10° x 10° field and approved by the internal quality program of the software (version 2.01).
Keratometry values were used for correction of magnification errors, and measurements
were repeated after surgery in all eyes operated upon (II, III). A mean three-dimensional
image was created from three single images. Stereophotographs of the ONH were used to
Table 2. Grading of eyes with glaucoma or ocular hypertension. Fellow eyes of the 50 patients in
Study IV and the 10 eyes in Study V were all normotensive and non-glaucomatous. Of patients in
Study V, only grading of the glaucomatous eyes is shown.
I II III IV V
Stage N % N % N % N % N %
1 34 24 11 14 10 20
2 37 27 23 29 11 22 2 20
3 37 27 2 20 26 32 14 28 4 40
4 20 14 5 50 13 16 10 20 4 40
5 6 4 4 5 5 10
6 5 4 3 30 2 2
7 1 1
N = number  of eyes
aid in drawing the contour line at the inner border of the scleral ring. The contour line of
the baseline image was exported to follow-up images (II, III). Pupils were dilated with
tropicamide and phenylephrine eye-drops before SLO imaging. A reference plane parallel
to the retinal surface was located 50 µm posteriorly to the mean contour line height in the
temporal segment between –10° and –4°.
5.4.6 Measurement of ONH and peripapillary retinal blood flow
ONH and peripapillary retinal blood flow was measured with a confocal scanning laser
Doppler flowmeter (SLDF); the Heidelberg Retina Flowmeter (HRF, Heidelberg
Engineering GmbH). All images were obtained with pupils dilated. Several images focused
on the peripapillary nerve fibre layer and centered in the upper, mid, and lower parts of the
ONH were obtained from each eye. Images were also obtained centered on the cup and
focused on the lamina cribrosa. Blood flow was quantified by placing a square of 10 x 10
pixels on the area of interest. These analyses avoided any visible vessels, horizontal strikes
caused by eye movements, or areas of peripapillary atrophy. The flow values were
measured at three locations on the neuroretinal rim and at five locations on the peripapillary
retina 0.6 to 0.8 mm from the scleral ring. One value was obtained from the bottom of the
optic cup.
5.4.7 Measurement of macular blood flow
Macular leucocyte velocity and density (number of leucocytes within the field of observation)
were subjectively measured by a blue-field simulation technique (BSF-2000, Oculix, Inc.,
Berwyn, PA, USA) (Riva & Petrig 1980, Sinclair et al. 1989). Both eyes were examined, the
left eye first. Subjects were seated in a darkened room in front of a blue-field entoptoscope
and a TV monitor. After hearing the technique explained, the subjects were asked to adjust
two dials until the velocity and density of the computer-simulated particles displayed on the
monitor matched those of their own entoptically observed leucocytes. Three matching trials
were performed for each eye, with velocity and density readjusted each time. Average
leucocyte velocity and density were calculated. To ensure that subjects were able to pass the
test reliably, the study included only those with a coefficient of variation (100 x standard
deviation / mean) between three measurements of less than 30% in both eyes.
5.5 RISK FACTORS FOR PROGRESSION (I)
5.5.1 Patients
Patients selected for the study were all 186 patients with ExOHT or ExG who had been
admitted into the glaucoma ward in 1993. The charts of these patients were reviewed. Study
entry was determined as the first visit to HUEH when a VF examination was performed
(also including visits before 1993). All patients (except those with stage of glaucoma > 6)
with at least one previous, at least one year old, VF available were invited to one additional
follow-up visit which included a clinical examination (by the author), a diurnal IOP curve,
and perimetry. After this, patients were included in the study if inclusion criteria were met:
1) at least two reliable VF examinations taken at the hospital glaucoma laboratory, 2) ≥ 1
year follow-up between two successive VFs, and 3) at the time of the first VF examination,
stage of glaucoma ≤ 6. Only one eye of each patient was included. In patients with bilateral
ExG or ExOHT, the eye diagnosed first was chosen. If ExG or ExOHT was diagnosed at
the same time in both eyes, the right eye was chosen. Of the 139 patients who met the
inclusion criteria, 101 were women and 38 men (mean age ± SD of 69.9 ± 7.7 years, range
50-88 years) (Table 1). The grading of the eyes at study entry is shown in Table 2.
Of the 47 patients excluded from the study; 14 had unreliable VFs, 27 had < 1 year follow-
up, and 6 had stage of glaucoma > 6 at the time of the first VF examination. Of those 27
with < 1 year follow-up, 7 did not accept the invitation for the additional follow-up, 13 had
died, and 7 had no previous VF available.
Patients included in the study were referred to HUEH (at study entry) because of
uncontrolled IOP (54 eyes, 39%), suspicion of progression (11 eyes, 8%), evaluation of the
glaucoma (32 eyes, 23%), cataract (12 eyes, 9%), a subjective (pain, blurred vision, or
other) symptom (9 eyes, 6%), recurrent dacryocystitis (1 eye), and some problem with the
fellow eye (15 eyes, 11%). Five patients (4%) were not referred, but study entry coincided
with a planned examination. Evaluation of glaucoma included cases for which the referral
ophthalmologist had no access to VF.
Follow-up ended 1) when progression was detected, or 2) at the time of the final VF in the
HUEH, if progression was not detected. The mean (±SD) follow-up time was 5.2 ± 3.6
years (range 1.0-19.8 years). On average, there were 2.0 ± 1.4 (range 1-7) follow-up visits
after the first reliable VF at the HUEH. Of the total of 139 patients, 58 had only one
follow-up VF included in the analysis: 34 patients with progression and 24 without
progression. Of these 34 with progression, 24 had more follow-up visits than this one, but
were not included because progression had already occurred. Of the 24 patients without
progression who had only one follow-up visit, the author examined 15. The mean time
interval between any two of the follow-up visits was 3.0 ± 2.2 years (range 0.5-14 years).
Progression was detected in 63 eyes (45.3%). This end-point was achieved at the additional
follow-up visit in 9 eyes (6%), but in 54 eyes (39%) progression had already been detected
already from the patient charts, based on earlier visits. Of these 54 eyes (or patients), 26
(19%) still attended the additional follow-up (although follow-up had already ended
because progression had occurred), whereas 27 (19%) did not: 8 patients (6%) did not
accept the invitation, 13 (9%) had died, and 1 (1%) could not be reached.
In 76 eyes (54.7%) no progression was detected during follow-up. Of these 76 eyes (or
patients), 21 patients (15%) did not appear for the additional control visit: 11 (8%) did not
accept the invitation, 7 (5%) had died, and 3 (2%) could not be reached. These eyes showed
no progression at the last visit in the HUEH, and it remains unknown whether progression
would have been detected in some of these 21 patients if they had attended the additional
visit.
5.5.2 Methods
At study entry and follow-up ambulatory visits, grading of glaucoma was performed. All
IOP values obtained from referral notes and measured at the hospital glaucoma laboratory
at any time were recorded. IOPs < 3 months after trabeculectomy or cataract operation, and
IOPs < 1 month after ALT or cyclodestruction were excluded. Data on intraocular
interventions, ocular diseases, and glaucoma medications were recorded as well as the
highest IOP value during the whole follow-up time. Treatments of the eyes before and by
the end of the study are shown in Table 3.
Table 3. Treatment of eyes before and by study-end (I)
Before entrance
Number of eyes %
By the study-end
Number of eyes %
No treatment 49 35.3 3 2.2
Medical treatment only 63 45.3 26 18.7
Medical + other* 22 15.8 91 65.5
Other only* 5 3.6 19 13.7
139 100 139 100
ALT 23 16.5 87 62.6
Surgical intervention
Trabeculectomy 3 2.2 45 32.4
Cyclodestruction 0 0 25 18.0
Laser iridectomy 0 0 13 9.4
Cataract operation 4 2.9 48 34.5
None 114 82.0 29 20.9
* = ALT or surgical intervention
ALT = argon laser trabeculoplasty
Progression was defined as entering into a more severe stage including conversion from
ExOHT to ExG.
In order to control for the length of follow-up and the different numbers of available IOP
readings between two follow-up visits, a weighted mean IOP was calculated to describe the
IOP level between two successive visits. For the calculations, the following formula was
created:
Weighted mean IOP =  ∑∑
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in which xi  is the mean IOP during the time period ti. In the formula, the means of all IOPs
measured between two successive follow-up visits were multiplied by time in years
between these two visits. These calculated values from all intervals were then added
together, and the sum was divided by the entire length of the follow-up time. Maximum
IOP was defined as the highest IOP recorded before the end of the study. Mean IOP was
calculated as the mean of the IOPs between follow-ups. IOP range was defined as the
difference between the highest and lowest IOP recorded before the end of the study.
To analyze time-to-event data, survival analysis was performed with the Cox proportional
hazards model. Progression was selected as the event or hazard, and the simultaneous effect
of the following factors on the hazard of progression were studied: age, gender, weighted
mean IOP, maximum IOP, mean IOP, IOP range, stage of glaucoma at the beginning of the
study, refraction (the spherical equivalent), glaucoma medication, and type of surgical
intervention.
5.6 EFFECT OF IOP REDUCTION ON ONH TOPOGRAPHY (II)
5.6.1 Patients
Ten eyes of nine consecutive patients scheduled for filtration surgery (trabeculectomy)
were enrolled in this study (mean age ± SD of 65.6 ± 8.1 years, range 55-75 years) (Table
1); four of the patients with ExG had also been included in Study I. All eyes underwent
trabeculectomies between June and November 1993. The indication for surgery was
progression or suspected progression of VF defects or uncontrollable IOP despite
maximum tolerable medication. A standard surgical procedure was performed on all eyes
(Raitta & Vesti 1991, Vesti 1993). The inclusion criterion was that measurable images with
HRT could be obtained. The stage of glaucoma was graded as moderate in two eyes and as
severe in eight. Grading of the eyes according to Thorburn’s classification (1988) is shown
in Table 2.
5.6.2 Methods
Diurnal IOP curves and SLO-imaging with the HRT were performed once before and twice
after surgery. The first follow-up visit was at 2 to 7 months (mean ± SD, 3.7 ± 1.7 months)
after surgery (follow-up A), and the second follow-up visit at 7 to 16 months (12.1 ± 3.2
months) after surgery (follow-up B). Cup volume (mm3) cup/disc area ratio, mean cup
depth (mm), and mean height of contour (mm) were obtained from the HRT analysis. The
percentage changes in IOP and in HRT parameters between the pre-operative and post-
operative situation were calculated: (post-values – pre-values) / pre-values x 100%.
5.7 ONH TOPOGRAPHY IN ExOHT AND ExG AND USE OF HRT
IN FOLLOW-UP (III)
5.7.1 Patients
All consecutive patients referred to HUEH between May 1995 and May 1997 because of
ExOHT or uncontrolled ExG were included. Further treatment of each patient was decided
by a senior ophthalmologist who examined the patients and chose one of the following
interventions: medical treatment (13 eyes), ALT (42 eyes), or trabeculectomy (25 eyes).
Patients with previous ALT were accepted into the study only if the senior ophthalmologist
chose trabeculectomy as the further treatment. Otherwise, patients who had undergone
ALT, trabeculectomy, or cyclodestruction were excluded. Only eyes with refraction errors
from -5.0 to +5.0 diopters were accepted. Eyes with a dense cataract making SLO-imaging
impossible were excluded.
A total of 80 patients, 31 men and 49 women (P < 0.05, Chi-Square test), met the criteria
(mean age ± SD of 68.7 ± 7 years, range 50-83 years) (Table 1).
5.7.2 Methods
Patients were followed prospectively and examined every 6 months, with analyses made at
6 months and 2 years. Examinations included clinical examination, diurnal measurement of
IOP, perimetry, and SLO-imaging of the ONH with the HRT. IOP was also measured
immediately after imaging. VFs were measured with the Octopus perimeter program G1. If
the patient was unable to perform reliable automated perimetry, Goldmann kinetic
perimetry was performed. The grading of the eyes at study entry is shown in Table 2. The
analyses were divided into three parts: 1) Study of the linear associations between HRT
parameters and disc area, and between HRT parameters and VF index mean defect (MD),
2) Study of the reversal of ONH topography associated with reduction of IOP from pre-
intervention level to the level at 6 months after intervention, and 3) Study of the association
between change in MD from 6 months to 2 years with subsequent change in HRT
parameters. Changes were calculated as ‘valuet2 – valuet1’, where t1 is the earlier time-point
and t2 the later time-point.
5.8 ONH AND PERIPAPILLARY RETINAL BLOOD FLOW IN
UNILATERAL ExG AND ExOHT (IV)
5.8.1 Patients
Fifty consecutive patients with uncontrolled unilateral ExG or ExOHT referred to the
HUEH between May 1996 and December 1997 were included (mean age ± SD of 67.8 ±
7.4 years, range 51-85 years) (Table 1); 36 of these patients had also participated in Study
III. All patients had ExOHT or ExG in only one eye, and these eyes comprised the study
group. The control group comprised the fellow eyes, which all had IOP less than 22 mmHg.
Of the control eyes, 14 were clinically non-exfoliative and 36 exfoliative. The type of
glaucoma medications used were topical ß-blocking agent in 29 eyes (25 with timolol, and
4 with betaxolol), pilocarpine in 17 eyes, dorzolamide in 10 eyes, oral acetazolamide in 4
eyes, and dipivefrine in 1 eye. Twenty-four eyes had more than one type of medication, 9
eyes only one type, and in 17 eyes IOP was controlled without medication (2 eyes because
of ALT and 15 eyes because of trabeculectomy). Systemic diseases and medications are
specified in Table 4.
5.8.2 Methods
Examinations included blood flow measurements of the ONH and peripapillary retina with
the HRF, SLO imaging of the ONH with the HRT, perimetry (Octopus perimetry program
G1 in 46 patients, Goldmann kinetic perimetry in 4), measurement of IOP, clinical exami-
Table 4. Systemic diseases and medications of patients in Study IV
Systemic diseases Number of
Patients
%
None 33 66
Systemic disease 17 34
Non-insulin-dependent diabetes mellitus 2  4
Systemic hypertension 12 24
Other cardiovascular disease 6 12
Systemic medications
None 35 70
Systemic medication 15 30
β-blocking agents 8 16
Calcium-channel antagonists 5 10
Angiotensin-converting enzyme-blockers 3  6
Diuretics 4  8
Acetylsalicylic acid 5 10
nation, and measurement of blood pressure (BP). The perfusion pressure of each eye was
calculated by the formula (diastolic BP + 1/3(systolic BP - diastolic BP)) - IOP (Hayreh
1994). Grading of the eyes is shown in Table 2. Mean (± SD) IOP measured immediately
after HRF measurements was significantly higher in the study eyes than in the control eyes
(19.2 ± 6.8 mmHg vs. 16.7 ± 4.1 mmHg respectively, P = 0.022), with no significant
difference detected in perfusion pressure (82.7 ± 13.9 mmHg vs. 84.9 ± 12.2 mmHg, P =
0.085). VF indices and all HRT parameters except maximum cup depth were significantly
worse in study eyes than in control eyes (Table 5). The mean (± SD) disc area in study eyes
was greater than in control eyes (1.92 ± 0.41 mm2 vs. 1.83 ± 0.37 mm2 respectively, P =
0.030).
Flow values were measured at three locations on the neuroretinal rim and at five locations
on the peripapillary retina 0.6 to 0.8 mm from the scleral ring. One value was obtained from
the bottom of the optic cup. The flow values were independent of location of measurement
in the rim area and in the peripapillary retina (F = 0.02 and P = 0.980 for rim, F = 1.14 and
P = 0.340 for peripapillary locations; repeated measures ANOVA). Therefore, the mean of
the values in three locations of the rim area and the mean of the values in five locations of
the peripapillary area were calculated for use in further analyses.
Table 5. Mean of VF indices and HRT parameters of study eyes and control eyes (IV)
Parameter Study eyes Control eyes P-value
Mean ± SD Mean ± SD
VF index (n = 46)
MS (dB) 17.4 ± 7.1 25.3 ± 2.3 <0.001*
MD (dB) 9.1 ± 7.2 1.3 ± 2.1 <0.001*
LV (dB) 32.2 ± 31.7 6.0 ± 4.7 <0.001*
HRT parameters
Disc area (mm2) 1.92 ± 0.41 1.83 ± 0.37   0.030*
Cup area (mm2) 0.84 ± 0.52 0.51 ± 0.31 <0.001*
Cup/disc area ratio 0.43 ± 0.21 0.27 ± 0.13 <0.001*
Rim area (mm2) 1.01 ± 0.41 1.32 ± 0.29 <0.001*
Height variation contour (mm) 0.31 ± 0.10 0.37 ± 0.09   0.001*
Cup volume (mm3) 0.21 ± 0.25 0.10 ± 0.09   0.001*
Rim volume (mm3) 0.23 ± 0.16 0.33 ± 0.12 <0.001*
Mean cup depth (mm) 0.29 ± 0.13 0.20 ± 0.08   0.008*
Maximum cup depth (mm) 0.56 ± 0.21 0.53 ± 0.16   0.151
Cup shape measure -0.10 ± 0.08 -0.18 ± 0.12 <0.001*
Mean RNFL thickness (mm) 0.17 ± 0.07 0.22 ± 0.06 <0.001*
RNFL cross-section area (mm2) 0.84 ± 0.34 1.07 ± 0.32 <0.001*
* = statistically significant
HRT = Heidelberg retina tomograph, LV = loss variance, MD = mean defect,
MS = mean sensitivity, VF = visual field, RNFL = retinal nerve fibre layer
The analyses were divided into two parts: 1) Study of factors associated with difference in
flow between study eyes and control eyes, and 2) Study of what factors associated with the
flow in study eyes only. In both situations, analyses were repeated for lamina area, rim area,
and peripapillary area separately. Differences were calculated as value of study eye minus
value of control eye.
Regarding differences in flow between study eyes and control eyes, associations with the
following factors were tested: difference in IOP, difference in VF index MD, differences in
the HRT parameters rim volume and RNFL cross-section area, stage of glaucoma in the
study eye, and whether the study eye was treated with timolol, betaxolol, pilocarpine and/or
dorzolamide, and whether ExS of the fellow eye had been diagnosed.
Regarding the flow in study eyes only, associations with the following factors were tested:
IOP, VF index MD, HRT parameters rim volume and RNFL cross-section area, stage of
glaucoma, whether the study eye was treated with timolol, betaxolol, pilocarpine and/or
dorzolamide, perfusion pressure of the eye, age of patient, whether the patient had systemic
hypertension or any cardiovascular disease, and whether the patient had been treated with a
systemic ß-blocker.
5.9 MACULAR BLOOD FLOW IN UNILATERAL ExG AND
ExOHT (V)
5.9.1 Patients
The study included 21 patients (mean age ± SD of 62.9 ± 7.9 years, range 50–74 years).
Three patients were excluded because of coefficient of variation above 30% of the blood flow
measurements. Patients were divided into two groups: one group with unilateral ExG (n = 10,
mean age ± SD of 61.1 ± 8.4 years, range 50–74 years) and the other group with unilateral
ExS (n = 11, mean age ± SD of 64.5 ± 7.5 years, range 49–74 years) (Table 1). All of the 10
patients with ExG participated in Study III and 7 also in Study IV. In the group with
unilateral ExG, all fellow eyes were healthy, clinically non-exfoliative, and normotensive. Of
the glaucomatous eyes, two had early glaucoma (with only optic disc changes), one had nasal
step in the VF, four had nasal step combined with Bjerrum scotoma, and in three eyes the
Bjerrum scotoma extended to the edge of the paracentral 10° field. Grading of the eyes
according to Thorburn’s classification (1988) is shown in Table 2. All glaucomatous eyes
had been receiving topical medication and four subjects received systemic carbonic anhydrase
inhibitor, as well. Topical medication included timolol in all 10 eyes, pilocarpine in seven
eyes, and dipivefrine in four eyes. One patient with ischaemic heart disease was receiving a
systemic calcium-channel blocker. In all glaucomatous eyes, IOP (measured immediately after
blue-field simulation) was less than 28 mmHg (mean ± SD, 23.5 ± 3.8 mmHg) and in all non-
glaucomatous eyes, IOP was less than 22 mmHg (17.3 ± 2.2 mmHg), which difference was
statistically significant (P = 0.01).
The group with unilateral ExS showed no signs of glaucoma in either eye. All patients had
ExS in one eye, and the other eye was clinically non-exfoliative. None had ever received IOP-
reducing medication. Four patients had systemic hypertension, and one also diabetes mellitus
type II. Systemic medication included calcium-channel blockers (1 patient), β-blocking agents
(2 patients), and angiotensin-converting enzyme-blockers (2 patients). The mean (± SD) of
the highest IOP of the diurnal IOP curve obtained the same day was 15.7 ± 2.2 mmHg for the
exfoliative eyes and 14.7 ± 1.9 mmHg for the non-exfoliative eyes; they did not differ
significantly (P = 0.33).
5.9.2 Methods
Examinations included clinical examination, measurement of IOP, perimetry (Octopus
perimetry program G1), and measurement of macular leucocyte velocity and density with
blue-field entoptic simulation.
Macular capillary leucocyte velocities and densities were analyzed for asymmetry within the
ExG and ExS groups. Differences were calculated as value of affected eye minus value of
clinically non-exfoliative eye, where the affected eye is the one with ExS or ExG. Leucocyte
velocity was correlated with MD, loss variance (LV), and IOP.
5.10 STATISTICAL METHODS
Statistical analyses were performed with the SPSS software package (version SPSS 8.0 for
Windows, SPSS Inc., Chicago, IL, USA) in Studies I, III, and IV, and the SAS software
package (SAS Institute Inc., Cary, NC, USA) in Studies II and V.
Variables were tested for normality with the one-sample Kolmogorov-Smirnov test (I-V).
For parametric comparisons of the means, the independent samples t-test was used for non-
paired comparisons (I) and a paired t-test for pairwise comparisons (III, IV, V). For non-
parametric variables, the Mann-Whitney U-test was used for unpaired comparisons (II) and
the Wilcoxon signed-rank sum test (II, V) for paired comparisons. Repeated measures
ANOVA was used to study whether location of measurement had any effect on flow values
(IV).
To test proportions, the Pearson chi-square test (I, III) was used and, if the expected
frequency was less than 5, Fisher’s exact test (I).
Pearson correlation (II, IV, V) and Spearman’s rank correlation (II, V) coefficients were
used for correlation analyses. Multiple linear regression analyses were performed with the
enter and stepwise procedures to study linear associations between variables in multivariate
situations (III, IV). Mallow’s Cp with a stepwise procedure was performed to select
variables for multiple linear regression analyses (IV); variables in the model with the
smallest Mallow’s Cp criterion were selected. The residuals were tested and found to be
normally distributed, homeoscedastic, and non-biased.
To analyze time-to-event data (I), survival analysis with the Cox proportional hazards
model was performed. In the Cox proportional hazards model, a forward stepwise
procedure was used. A probability of the score statistic of 0.05 or less was required for
entry into the model, and removal was based on a probability greater than 0.10 for the
likelihood-ratio statistic.
A P-value < 0.05 was considered statistically significant.
6 RESULTS
6.1 RISK FACTORS FOR PROGRESSION (I)
Progression of glaucoma (entering into a more severe stage) was detected in 63 eyes
(45.3%), whereas 76 eyes (54.7%) showed no progression. Factors affecting progression
were studied with the Cox proportional hazards method, which resulted in the model shown
in Table 6. A significant association with progression was found for age, weighted
Table 6. Results of Cox proportional hazards model (I). Factors associated with progression of
exfoliation glaucoma shown.
Covariate Regression
coefficient
Relative risk 95% Confidence
Interval
P-value
Age
by 1 year increase 0.041 1.042 1.001-1.084     0.043*
Weighted mean IOP
by 1 mmHg increase 0.073 1.076 1.037-1.116 < 0.001*
Stage of glaucoma
by 1 stage increase 0.362 1.436 1.173-1.756 < 0.001*
History of
trabeculectomy -1.022 0.360 0.187-0.694    0.002*
* = statistically significant
IOP = intraocular pressure
mean IOP, and stage of glaucoma. History of trabeculectomy was related to decreased risk.
No significant association with progression was found for gender, maximum IOP,
refraction, glaucoma medication, history of ALT, or history of cyclodestruction. A one-year
increase in age increased relative risk for progression by 4.2%. Similarly, a one-mmHg
increase in weighted mean IOP increased relative risk by 7.6%, and a one-step increase in
staging of glaucoma increased relative risk by 43.6%. If trabeculectomy was not performed,
the estimated risk for progression was 2.78 times as great (1 / 0.36 = 2.78). The effect of
trabeculectomy on progression is also shown graphically in Figure 1, in which the
estimated survival curves for eyes operated on and not operated on are plotted separately.
Eyes that had been operated on remained non-progressive longer than those not operated
on. The weighted mean IOP did not differ significantly between eyes with and without a
history of trabeculectomy (mean ± SD, 19.71 ± 6.3 mmHg and 21.0 ± 5.7 mmHg
respectively, P = 0.226).
Figure 1. Cumulative survival for eyes with and without a history of trabeculectomy
There were 21 eyes without progression that did not attend the additional follow-up visit.
Comparison of these patients with the others revealed that these patients were older and
more often treated with dipivefrine (Table 7). There were no statistically significant
differences in the other covariates that were used in the analyses. The length of follow-up
of these 21 patients did not differ significantly from that of all other patients (mean ± SD,
4.4 ± 3.7 and 5.4 ± 4.4 years respectively, P = 0.238), nor from follow-up lenght of the
other 55 censored (non-progressing) patients (4.4 ± 3.7 and 5.5 ± 3.1 years, P = 0.151).
Analysis with the Cox proportional hazards method was repeated for 118 eyes with these
21 eyes excluded, but the results remained unaffected.
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Table 7. Covariates used in the Cox proportional hazard model compared between 21 eyes
without progression that did not attend the additional follow-up and all the other 118 eyes (I)
Covariates N = 118 N = 21 P
Age (mean ± SD, years) 69.1 ± 7.5 74.6 ± 7.6 0.003*
Gender (men/women) 35 / 83 5 / 16 0.585
Maximum IOP (mean ± SD, mmHg) 29.1 ± 11.7 27.0 ± 7.6 0.429
Mean weighted IOP (mean ± SD,
mmHg)
20.7 ± 6.8 19.8 ± 4.1 0.511
Stage of glaucoma#
1 28  (24%) 6  (28%) 0.487
2 31  (26%) 6  (29%)
3 30  (25%) 7  (33%)
4 19  (16%) 1  (5%)
5 5    (4%) 1  (5%)
6 5    (4%) 0
Refraction (D) -0.27 ± 3.0 0.35 ± 1.5 0.369
Medication for glaucoma
β-blocking agent 95  (80%) 15  (71%) 0.345
Pilocarpine 79  (67%) 12  (57%) 0.383
Oral acetazolamide 42  (36%) 3  (14%) 0.055
Dipivefrine 16  (14%) 7  (33%) 0.049*
Dorzolamide† 8   (7%) 0 0.260
Surgical intervention
ALT 72  (61%) 15  (71%) 0.364
Cyclodestruction 21  (18%) 4  (19%) 1.000
Trabeculectomy 40  (34%) 5  (24%) 0.363
* = statistically significant
# = Stages 4, 5, and 6 were combined as one group in analysis
† = Fisher’s exact test
ALT = argon laser trabeculoplasty, IOP = intraocular pressure, N = number of eyes
For descriptive statistics, a risk score for each of the 139 patients was calculated from the
Cox proportional hazards model. The formula for the risk score can be written as follows:
Risk score = (0.041) (age) + (0.073) (weighted mean IOP) + (0.362) (stage of glaucoma) +
(-1.022) (history of trabeculectomy), i.e., the value of each covariate is multiplied by the
regression coefficient (Table 6) of the same covariate. The value for history of
Table 8. Based on the Cox proportional hazards model, a risk score was calculated for every patient (I). Based on risk score, patients were divided in three
groups equal in size, to show characteristics of covariates in the low-, medium-, and high-risk groups.
Covariate Descriptive
statistic
All eyes
Mean (± SD) risk
score = 4.976 ± 0.793
N = 139
Low risk
Risk score < 4.633
N = 46
Medium risk
Risk score ≥ 4.633
and ≤ 5.315
N = 47
High risk
Risk score > 5.315
N = 46
Age (years) Mean (±SD) 69.9 ± 7.7 65.1 ± 6.4 71.1 ± 7.2 73.6 ± 7.1
Range 50.8-88.7 51.7-81.6 50.8-82.5 58.3-88.7
Weighted mean IOP Mean (±SD) 20.6 ± 5.8 18.5 ± 4.0 19.7 ± 5.2 23.6 ± 6.8
(mmHg) Range 8.2-42.0 8.2-25.0 11.0-42.0 14.5-40.8
Stage of glaucoma Mean (±SD) 2.6 ± 1.3 2.3 ± 1.3 2.2 ± 1.1 3.2 ± 1.4
Range 1-6 1-6 1-5 1-6
History of trabeculectomy Frequency 45 eyes 33 eyes 8 eyes 4 eyes
Percent 32.4% 71.7% 17.0% 8.7%
IOP = intraocular pressure, N = number of eye
trabeculectomy is 1 if operated on and 0 if not. Based on risk scores, the patients were
divided into three groups of equal size: 1) a low-risk group with risk scores less than 4.633,
2) a medium-risk group with scores between or equal to 4.633 and 5.315, and 3) a high-risk
group with scores above 5.315 (Table 8). Progression was observed in 14 (30%), 22 (47%),
and 27 eyes (59%) in the low-, medium-, and high-risk groups, respectively. Mean age,
weighted mean IOP, and stage of glaucoma increased towards the high-risk group.
Frequency of trabeculectomy was lowest in the high-risk group: of the 46 eyes classified as
low-risk, 33 (71.7%) had undergone trabeculectomy compared to only 8 (17%) and 4 eyes
(8.7%) in the medium- and high-risk groups, respectively. In the low-risk group, no eye had
a weighted mean IOP above 25 mmHg (range 8.2-25.0 mmHg).
6.2 EFFECT OF IOP REDUCTION ON ONH TOPOGRAPHY (II)
At follow-up A (3.7 months after trabeculectomy), the mean (± SD) drop in mean diurnal
IOP was 13.4 ± 6.9 mmHg or 52.2 ± 12.5% (Table 9). Mean values for cup volume and
mean cup depth were significantly smaller than pre-operative values. The cup/disc area
ratio and mean height contour showed no significant changes. At follow-up A, all eyes
showed a drop in diurnal IOP of more than 35% (36.4–60.6%). Three eyes showed a
decrease in cup volume of less than 10%: one eye with 6% decrease in cup volume had
experienced an IOP > 25 mmHg during the first post-operative week, one eye with a 10%
decrease had NTG, and one eye with a 46% increase in cup volume had bleb failure and
underwent bleb revision 1.5 months after surgery. All other eyes underwent a decrease in
cup volume of 24% to 53%.
At follow-up B (12.1 months after trabeculectomy), measurable images of two eyes could
not be obtained because of cataract, and these eyes were not included in the analyses of this
follow-up. The mean (± SD) drop in IOP when compared to preoperative values was 11.8 ±
8.2 mmHg or 41.4 ± 23.8% (Table 9). A statistically significant decrease was found for cup
volume, cup/disc area ratio, and mean height of contour. No significant change was found
for mean cup depth. A more than 30% decrease in cup volume (34–57%) was detected for
six of eight eyes; all these eyes showed a drop in IOP of more than 30% (33–67%). The
other two eyes showed slight increases in cup volume (12% and 5%, respectively) and had
the smallest percentage decrease in IOP (14% and 0%) and the smallest IOP reduction (3
Table 9. Mean IOP, mean HRT parameters, and percent change in parameters from before
trabeculectomy (Pre) to the first (Post A) and second (Post B) follow-ups (II)
Pre
Mean (± SD)
Post A
Mean (± SD)
% Change
Mean (± SD)
P value
IOP (mmHg) 24.4 ± 6.9 11.0 ± 2.8 -52.8 ±12.5 < 0.05*
Cup volume (mm3) 0.65 ± 0.44 0.50 ± 0.35 -31.8 ± 16.2 < 0.05*
Cup/disc area ratio 0.66 ± 0.15 0.62 ± 0.19 -5.9 ± 22.2 NS
Mean cup depth (mm) 0.48 ± 0.30 0.34 ± 0.19 -13.8 ± 12.1 < 0.05*
Mean height of contour (mm) 0.14 ± 0.44 0.12 ± 0.03 -11.0 ± 23.7 NS
Pre
Mean (± SD)
Post B
Mean (± SD)
% Change
Mean (± SD)
P value
IOP (mmHg) 25.5 ± 7.3 13.8 ± 3.1 -41.4 ± 23.8 < 0.05*
Cup volume (mm3) 0.76 ± 0.42 0.52 ± 0.38 -32.0 ± 25.9 < 0.05*
Cup/disc area ratio 0.71 ± 0.12 0.64 ± 0.16 -12.3 ± 16.7 < 0.05*
Mean cup depth (mm) 0.55 ± 0.30 0.42 ± 0.14 15.6 ± 18.6 NS
Mean height of contour (mm) 0.15 ± 0.04 0.09 ± 0.05 36.9 ± 28.9 < 0.05*
* = statistically significant
IOP = intraocular pressure, NS = not significant
 and 0 mmHg); they were one eye with IOP > 25 mmHg during the first post-operative
week and one eye with NTG.
6.3 ONH TOPOGRAPHY IN ExOHT AND ExG AND USE OF HRT
IN FOLLOW-UP (III)
Before intervention, mean (± SD) diurnal IOP was 24.4 ± 6.1 mmHg, mean IOP (± SD)
measured after HRT imaging 28.2 ± 9.0 mmHg, and mean (± SD) VF index MD 8.6 ± 6.6
(Table 10). At this baseline examination, the associations between HRT parameters, VF
index MD, and disc area were studied.
Table 10. Mean of IOP and VF indices before intervention and at follow-up visits at 6 months
and 2 years
Pre-intervention
Mean (±SD)
6 months
Mean (±SD)
P-value 2 years
Mean (±SD)
P-value
Mean diurnal IOP
(mmHg)
24.4 ± 6.1 16.2 ± 3.9 <0.001* 17.7 ± 3.2 <0.001*
IOP after HRT
(mmHg)
28.2 ± 9.0 17.7 ± 6.1 <0.001* 19.2 ± 5.0 <0.001*
MS (dB)# 17.9 ± 6.5 18.6 ± 5.9 0.022* 19.3 ± 5.8 0.011*
MD (dB)# 8.6 ± 6.6 7.7 ± 5.9 0.020* 7.1 ± 5.8 0.003*
LV (dB)# 26.4 ± 24.0 29.6 ± 28.4 0.750 27.2 ± 27.2 0.954
* = statistically significant
# = tested with Wilcoxon signed-rank sum test, the others with paired t-test
HRT = Heidelberg retina tomograph, IOP = intraocular pressure, LV = loss variance, MD = mean
defect, MS = mean sensitivity
6.3.1 Correlation of HRT parameters with VF index MD
At the baseline examination, when the effect of disc area was taken into account in the
multiple regression analyses, a statistically significant linear association existed between
MD and all HRT parameters (Table 11).
6.3.2 Covariation of HRT with disc area
At the baseline examination, the optic disc area showed a significant association with cup
area, cup/disc area ratio, rim area, cup volume, and mean RNFL thickness; the larger the
disc, the more likely that the HRT parameters would show values in the direction of ‘more
glaucomatous’ (Table 11). Associations with borderline significance occurred between disc
area and height variation contour and cup shape measure. Rim volume, mean cup depth,
maximum cup depth, and RNFL cross-section area appeared to be unaffected by area of the
ONH.
Table 11. Results of multiple linear regression analysis showing associations between HRT
parameters and MD (dB) and disc area (mm2)
Dependent variable R-square Explanatory
variable
PRC P-value
Cup area (mm2) 0.65 MD  0.030 < 0.001*
Disc area  0.787 < 0.001*
Cup/disc area ratio 0.32 MD  0.013 < 0.001*
Disc area  0.119    0.006*
Rim area (mm2) 0.26 MD -0.030 < 0.001*
Disc area  0.213    0.018*
Height variation contour (mm) 0.24 MD -0.006    0.001*
Disc area -0.041    0.065
Cup volume (mm3) 0.53 MD  0.024 < 0.001*
Disc area  0.294 < 0.001*
Rim volume (mm3) 0.21 MD -0.010 < 0.001*
Disc area  0.006  0.861
Mean cup depth (mm) 0.28 MD  0.010 < 0.001*
Disc area  0.045  0.130
Maximum cup depth (mm) 0.17 MD  0.011    0.001*
Disc area  0.047  0.317
Cup shape measure 0.26 MD  0.006 < 0.001*
Disc area  0.042    0.052
Mean RNFL thickness (mm) 0.26 MD -0.004 < 0.001*
Disc area -0.029    0.042*
RNFL cross section area (mm2) 0.20 MD -0.021 < 0.001*
Disc area  0.040  0.561
* = statistically significant
HRT = Heidelberg retina tomograph, MD = mean defect, PRC = partial regression coefficient,
RNFL = retinal nerve fibre layer
6.3.3 Reversal of ONH topography
After intervention, the mean IOP of the diurnal curve and IOP measured after HRT
decreased significantly from pre-intervention levels (Table 10). Of the VF indices, MD and
MS improved significantly compared to pre-intervention values. The reversal of HRT
parameters associated with reduction of IOP from pre-intervention to the level at 6 months
after intervention was studied.
Decrease in IOP (measured after HRT) was associated with a significant decrease in cup
area, cup/disc area ratio, cup volume, mean cup depth, and maximum cup depth, and a
significant increase in rim area and rim volume, when effects of age, stage of glaucoma,
and disc area were taken into account (Table 12). No association appeared between change
in IOP and height variation contour, cup shape measure, mean RNFL thickness, or RNFL
cross-section area. Stage of glaucoma showed a significant association only with changes in
cup volume and mean cup depth; these variables decreased more in eyes with advanced
glaucoma than in eyes with early glaucoma. Age showed a significant association with
changes in cup volume, mean cup depth, and maximum cup depth; in older patients, values
for these variables decreased more than in younger patients.
6.3.4 Association between change in MD and changes in HRT
parameters at sequential examinations
To study whether change in MD was associated with change in HRT parameters, the period
from 6 months to 2 years was analyzed. Reliable VFs taken with Octopus G1 both at 6
months and at 2 years were available for only 56 eyes. IOP (±SD), measured after imaging,
increased from 16.8 ± 3.8 mmHg at 6 months to 18.0 ± 4.5 mmHg at 2 years (P = 0.052). A
total of 31 eyes showed improvement in MD (range 0.10-5.20 dB) and 25 eyes impairment
in MD (range 0.1-4.10 dB). The mean change in MD was non-significant (mean ± SD, 6.9
± 4.9 dB at 6 months, 6.7 ± 5.2 dB at 2 years, P = 0.487).
Possible factors affecting HRT parameters (mean diurnal IOP at 2 years, change in IOP
measured after imaging from 6 months to 2 years, age of patient at first visit, and disc area)
were put into the multiple linear regression model as a block with the enter procedure. Then
a second block which included all HRT parameters (changes from 6 months to 2 years) was
added to the model with the stepwise procedure. The only HRT parameter picked up with
the stepwise procedure was change in cup shape measure, and it was taken into the model.
The analysis with cup shape measure and the other factors (mean IOP, change in IOP, age,
and disc area) was performed with the enter procedure, and resulted in a partial regression
coefficient (PRC) of 17.21 (P = 0.013) for cup shape measure. After exclusion of three
eyes considered outliers, the enter procedure was repeated, the result of which is shown in
Table 13. Increase in MD was associated with increase in cup shape measure (PRC = 6.3, P
= 0.046). The partial regression plot for change in cup shape measure and change in MD is
shown in Figure 2.
Table 12. Results of multiple linear regression analysis, showing associations between changes
in HRT from pre-intervention to 6 months with change in IOP (from pre-intervention to 6 months,
mmHg), disc area (mm2), age of patient (year), and stage of glaucoma
Dependent variable
(change in)
R-
square
Explanatory
variable
PRC
x 10-3
P-value
Cup area (mm2) 0.29 IOP change 5.25 < 0.001*
Disc area -5.77  0.814
Age 2.22  0.164
Stage of glaucoma -4.52  0.678
Cup/disc area ratio 0.26 IOP change 2.16 < 0.001*
Disc area 1.39  0.902
Age 1.06  0.150
Stage of glaucoma -2.82  0.573
Rim area (mm2) 0.26 IOP change -4.50 < 0.001*
Disc area 2.96  0.900
Age -2.54  0.098
Stage of glaucoma 1.83  0.861
Height variation contour (mm) 0.22 IOP change -1.02  0.085
Disc area 29.58    0.022*
Age -1.54  0.063
Stage of glaucoma 7.51  0.184
Cup volume (mm3) 0.39 IOP change 3.04    0.003*
Disc area -42.87    0.046*
Age 4.39    0.002*
Stage of glaucoma -22.62    0.018*
Rim volume (mm3) 0.16 IOP change -1.38    0.006*
Disc area 11.78  0.272
Age -0.42  0.547
Stage of glaucoma 3.36  0.479
Mean cup depth (mm) 0.35 IOP change 1.24    0.007*
Disc area 1.30  0.893
Age 1.61    0.001*
Stage of glaucoma -13.94    0.002*
Maximum cup depth (mm) 0.24 IOP change 2.33    0.008*
Disc area -9.01  0.629
Age 2.44    0.045*
Stage of glaucoma -15.11  0.071
Cup shape measure 0.06 IOP change 0.32  0.513
Disc area 10.54  0.319
Age 0.25  0.713
Stage of glaucoma -7.41  0.117
Mean RNFL thickness (mm) 0.08 IOP change -0.51  0.154
Disc area 13.31  0.084
Age -0.44  0.376
Stage of glaucoma -1.42  0.675
RNFL cross-section area (mm2) 0.08 IOP change -2.66  0.141
Disc area 65.51  0.094
Age -2.551  0.319
Stage of glaucoma -7.70  0.655
* = statistically significant
HRT = Heidelberg retina tomograph, IOP = intraocular pressure, PRC = partial regression
coefficient, RNFL = retinal nerve fibre layer
Table 13. Results of multiple linear regression analysis for changes from 6 months to 2 years,
with associations between change in MD and explanatory variables
Dependent variable R-square Explanatory variable PRC P-value
Change in MD (dB) 0.25 Mean IOP at 2 years (mmHg) -2.49 x 10-2 0.581
Change in IOP (mmHg) 0.127 0.056
Age (year) 6.69 x 10-2 0.033*
Disc area (mm2) 1.185 0.010*
Change in
cup shape measure
6.305 0.046*
* = statistically significant
MD = mean defect, PRC = partial regression coefficient, IOP = intraocular pressure
The analysis was repeated with the enter procedure by taking each of the HRT parameters
separately, each together with all the other variables (mean IOP, change in IOP, age, and
disc area) as explanatory variables. MD served as the dependent variable. Still, only cup
shape measure reached statistical significance at the 0.05 level.
Figure 2. Partial regression plot of change in cup shape measure and change in MD (dB) (III)
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6.4 ONH AND PERIPAPILLARY RETINAL BLOOD FLOW IN
UNILATERAL ExG AND ExOHT (IV)
The results of all analyses of HRF measurements of laminar, rim, and peripapillary retinal
blood flow are summarized in Table 14.
6.4.1 Blood flow in study eyes versus control eyes
Flow in the rim area of the study eyes was 172.1 arbitrary units higher than in control eyes
(P = 0.001). Similarly, flow in the laminar area of the study eyes was 39.5 arbitrary units
higher than in control eyes, but was only of borderline significance (P = 0.065). No
significant difference existed in peripapillary retinal blood flow (P = 0.531).
6.4.2 Blood flow related to degree of glaucomatous damage
More advanced glaucomatous damage was associated with reduced flow both in the
laminar area and in the rim area. In the analysis of difference in flow between study eyes
and control eyes, reduced rim area flow was associated with greater difference in MD (PRC
= -8.8; P = 0.013). In analysis of study eyes only, smaller rim volume was associated with
lower flow values in the lamina (PRC = 169.1; P = 0.024) and rim area (PRC = 284.6; P =
0.020).
6.4.3 Blood flow in eyes treated with timolol
Treatment with timolol was associated with reduced flow in the lamina and rim area. In the
analysis of difference in flow between study eyes and control eyes, treatment with timolol
was associated with increased difference in flow in the lamina (PRC = -76.4; P = 0.022)
and rim area (PRC = -146.2; P = 0.004). Also in the analysis of study eyes only, treatment
with timolol was associated with reduced flow in the lamina (PRC = -63.0; P = 0.001). The
association in the rim area (PRC = -63.6) was of borderline significance (P = 0.077).
Table 14. Results of multiple linear regression analyses for flow in the laminar, rim, and peripapillary area. In analyses of differences between study eyes
and control eyes, differences in flows were used as dependent variables. In analyses for flow in study eyes only, flows of the study eyes in corresponding areas
were used as dependent variables
Difference between study eyes and control eyes Study eyes
R-square Explanatory variable PRC P-value R-square Explanatory variable PRC P-value
Laminar flow 0.14 Timolol -76.4 0.022* 0.32 Rim volume (mm3) 169.1 0.024*
Pilocarpine 55.6 0.108 Timolol -63.0 0.001*
Intercept 39.5 0.065 Age of the subject (year) 5.1 0.002*
Rim area flow 0.25 Difference in MD (dB) -8.8 0.013* 0.15 Rim volume (mm3) 284.6 0.020*
Timolol -146.2 0.004* Timolol -63.6 0.077
Betaxolol -197.7 0.026*
Intercept 172.1 0.001*
Peripapillary 0.04 ExS of fellow eye 30.5 0.173 0.13 Perfusion pressure (mmHg) 1.8 0.021*
area Intercept -38.4 0.531
* = statistically significant
MD = mean defect, PRC = partial regression coefficient, ExS = exfoliation syndrome
6.4.4 Other findings
Four eyes treated with betaxolol seemed to have reduced flow in the rim area; the
difference in rim area flow between study eyes and control eyes increased in these eyes
(PRC = -197.7, P = 0.026). In study eyes, higher age was associated with increased flow in
the lamina (PRC = 5.1, P = 0.002). Increased perfusion pressure was associated with
increased flow only in the peripapillary retina (PRC =1.8, P = 0.021).
6.5 MACULAR BLOOD FLOW IN UNILATERAL ExG AND
ExOHT (V)
6.5.1 Macular blood flow in unilateral ExG
Mean leucocyte velocity as measured with the blue-field simulation technique differed
significantly between eyes (P = 0.02). Mean (± SD) leucocyte velocity was 0.70 ± 0.25
mm/s for the glaucomatous eyes and 0.89 ± 0.34 mm/s for their non-glaucomatous fellow
eyes (Table 15). Leucocyte velocity was lower in the glaucomatous eye in six patients,
equal in two, and higher in the glaucomatous eye in two patients. Leucocyte densities did
not differ significantly between eyes (P = 0.89).
Difference between eyes in leucocyte velocity did not correlate significantly with
difference in MD (r = -0.25, P = 0.49), with difference in LV (r = -0.33, P = 0.36), or with
difference in IOP (r = -0.46, P = 0.18). However, in the glaucomatous eyes, correlation of
borderline significance was detected between leucocyte velocity and MD (r = -0.58, P =
0.08; result not presented in V) (Figure 3), and between leucocyte velocity and LV (r =
-0.62, P = 0.06) (Figure 4). Leucocyte velocity did not correlate in the glaucomatous eyes
with IOP (r = -0.12, P = 0.75).
6.5.2 Macular blood flow in unilateral ExS
Neither leucocyte velocity nor leucocyte density differed significantly between eyes (P =
0.69 and P = 0.74, respectively).
Table 15. Mean leucocyte velocity (mm/s) and density (particles/field) of macular capillaries
measured with blue-field entoptic simulation in 10 patients with unilateral exfoliation glaucoma
and 11 patients with unilateral exfoliation syndrome.
Glaucomatous eye Non-glaucomatous eye Difference between eyes
Patient Velocity Density Velocity Density IOP Velocity%
1a 1.08 211 1.45 182 10 -25.5
2a 0.66 126 1.05 167 3 -37.1
3a 0.45 113 0.91 103 11 -50.5
4a 0.36 101 0.63 162 12 -42.9
5a 1.06 67 1.47 83 4 -27.9
6a 0.43 112 0.65 77 8 -33.8
7a 0.66 68 0.64 100 3 3.1
8a 0.86 91 0.73 78 7 17.8
9a 0.62 123 0.54 111 2 14.8
10a 0.77 92 0.80 56 2 -3.8
Mean
(±SD)
0.70 ± 0.25* 110 ± 41 0.89 ± 0.34* 112 ± 44 6.2 ± 3.9
Exfoliative eye Non-exfoliative eye Difference between eyes
Patient Velocity Density Velocity Density IOP Velocity%
1b 0.62 185 0.77 196 -1 -19.5
2b 0.65 # 0.71 # 0 -8.5
3b 0.93 # 0.50 # 2 86.0
4b 0.63 222 0.71 146 -2 -11.3
5b 0.58 234 0.60 251 0 -3.3
6b 1.06 65 1.25 53 0 -15.2
7b 0.65 179 0.67 191 4 -3.0
8b 0.72 77 0.55 88 2 30.9
9b 0.66 154 0.47 170 2 40.2
10b 0.84 33 0.70 93 -1 20.0
11b 0.63 65 0.78 63 0 -19.2
Mean
(±SD)
0.72 ± 0.15 135 ± 76 0.70 ± 0.21 139 ± 68 0.5 ± 1.8
* = Statistically significant, P = 0.02 (paired t-test)
# = Excluded from analysis of leucocyte densities because of coefficient of variation > 30%
IOP = intraocular pressure
Figure 3. Scatterplot showing correlation between MD (dB) and leucocyte velocity (mm/s)
measured by blue-field entoptoscopy in the macular area of glaucomatous eyes (V)
MD = mean defect
Figure 4. Scatterplot showing correlation between LV (dB) and leucocyte velocity (mm/s)
measured by blue-field entoptoscopy in the macular area of glaucomatous eyes (V)
LV = loss variance
The difference between eyes in leucocyte velocity did not correlate significantly either with
difference in MD (r = -0.15, P = 0.66), LV (r = 0.22, P = 0.52), or IOP (r = 0.46, P = 0.15).
Similarly, neither in exfoliative eyes nor in non-exfoliative eyes did leucocyte velocity
correlate with MD (r = -0.07, P = 0.83 and r = -0.43, P = 0.18), LV (r = -0.27, P = 0.41 and
r = -0.31, P = 0.35), or IOP (r = 0.18, P = 0.60 and r = -0.06, P = 0.85).
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7. DISCUSSION
7.1 PATIENTS AND METHODS
The study included a total of 249 patients, 238 of whom had glaucoma or OHT in at least
one eye. Most patients referred to the HUEH for consultation represent more complicated
cases than do the glaucoma cases in the total population, on average. This is a handicap in
this and all clinic-based studies, because results may not be generalisable to the whole
population. In Study I, of all 139 eyes, 65 (47%) were referred because of uncontrolled IOP
level or suspicion of glaucoma; however, some were also referred because of cataract,
problems with the contralateral eye, or symptoms not necessarily associated with glaucoma.
In the studies on ocular blood flow (IV, V), patients had unilateral ExG, unilateral ExOHT,
or unilateral ExS. The fellow eyes were used as controls to minimise the effect of systemic
diseases and medications, because these were expected to have similar effects on both eyes.
The population of Study IV can be criticised to be non-homogenous, because study eyes
had ExOHT (10 eyes) or ExG (40 eyes), and fellow eyes had ExS (36) or non-ExS (14
eyes). However, it is known that eyes with ExS in combination with high IOP (ExOHT) are
at increased risk for developing glaucoma (Pohjanpelto 1986). Further, eyes with OHT and
clinically non-glaucomatous ONHs have been shown, when examined with scanning laser
tomography, to have ONH changes that distinguish them from healthy eyes (Hatch et al.
1997). They may therefore represent an early stage of glaucomaone not yet clinically
detectable. Similarly, the non-exfoliative fellow eye of an exfoliative eye may also be
exfoliative, but at too early a stage to be detected clinically (Schlötzer-Schrehardt et al.
1991, Kivelä et al. 1997).
Glaucoma was graded in 7 stages according to a system which is a slight modification from
that of Thorburn (1988). He admits that the system is rough and the steps between stages
are unequal. Early stages may require more damage to the nerve fibres than do advanced
stages before progression to another stage is evident. Study I covered risk factors for
progression of ExG; progression was defined as entering another stage. Since grading of
glaucoma was rough, a change from one stage to another would indicate real progression
and not fluctuation. On the other hand, some damage to nerve fibres may have occurred
without the VF’s advancing to another stage. However, the rough staging system was
advantageous also because of the retrospective nature of the study, in which standardisation
of the VF examination was impossible. In the other studies, the grading system was used
merely to describe current glaucoma status.
Study I had 21 patients without progression that did not attend the additional follow-up.
Comparison of these 21 patients with all the others showed that these patients were older
(Table 7). Thus, their inclusion have diminished the effect of age on the progression, but
age was still a significant risk factor in the survival analysis. When analysis was performed
with only 118 eyes, these 21 eyes excluded, the result of the Cox regression model
remained the same.
Ocular blood flow was examined with SLDF and blue-field entoptoscopy. SLDF offers a
method for non-invasively measuring actual blood flow, instead of blood flow-related
parameters such as velocity (Pillunat 1999). However, the HRF may have some restrictions
because of variability of measurements. Reliability coefficients for repeated volume, flow,
and velocity measurements have been reported to be between 0.81 and 0.85 (Michelson &
Schmauss 1995, Michelson et al. 1996b). However, others have questioned the
reproducibility and variability of this method (Kagemann et al. 1998, Jonescu-Cuypers et
al. 1999). One problem also in this study is that small movements of the measurement
square may lead to considerable variation in flow values. Recently, a new method has been
developed for calculation of blood flow which includes all pixels of the perfusion image,
and this has improved the coefficient of reliability (Michelson et al. 1998b). Such software,
however, was unavailable for this study. The rather small R-squares in the multiple
regression analyses in this study may be explained by high variation in blood flow
measurements, or by the fact that other factors not examined in the present study also may
affect ocular blood flow.
It is not known exactly from what layers HRF measures blood flow. Blood flow to the most
superficial nerve fibre layer on the rim is mainly supplied by recurrent retinal arterioles
branching from the retinal arteries (Cioffi & Van Buskirk 1996). It is possible therefore
that values obtained in this study from the rim area may be affected not only by flow from
the short posterior ciliary arteries, but also by flow from the recurrent retinal arterioles.
Blood flow to the prelaminar and laminar regions of the ONH is supplied mainly by the
short posterior ciliary arteries (Cioffi & Van Buskirk 1996). Flow in the laminar area was
measured while focusing on the lamina, and the square used for measurement was placed in
the middle of the excavation. It can therefore be argued that the flow values obtained in the
laminar area should mainly reflect the flow supplied by the short posterior ciliary arteries. It
is, however, unknown whether the penetration depth of the HRF is appropriate for study of
the flow of these arteries. Petrig et al. (1999) studied ONH blood flow with a laser Doppler
flowmetry technique based on principles similar to HRF, but which penetrates to a depth of
1000 µm (Koelle et al. 1993) instead of 300 µm in HRF (Michelson et al. 1996). When
they occluded experimentally the central retinal artery or posterior ciliary arteries or both
and then measured ONH blood flow, they concluded that this technique was most sensitive
for blood flow measurements of the superficial layer of the ONH, but less sensitive for
blood flow in the deeper ONH layers; the latter they considered the area of interest in
glaucoma. Thus it may be questionable whether HRF with even less penetration depth is
actually affected by flow from the short posterior ciliary arteries. In the peripapillary retina,
the HRF measurements may reflect not only the retinal capillary bed, but also more deeper
layers, i.e., the choriocapillaris (Holló et al. 1997a).
The HRF measurements are affected by the image brightness, so that a brighter image or
image area results in lower flow values (Tsang et al. 1999, Kagemann et al. 2001). This is
probably due to the HRF noise-correction algorithm, which automatically corrects (i.e.,
reduces) the flow values more in bright images or areas (Tsang et al. 1999). Another
problem is that the acquisition of an HRF image takes two seconds, thus containing flow
values during one or two heartbeats. The difference between systolic and diastolic flow
measured with HRF may be up to 50% (Michelson et al. 1998b). Differences in image
brightness, and the pulsatility of flow may both cause bias. In the present study, however,
there should be no systematic error; the images acquired from glaucomatous eyes would
tend to be systematically darker or brighter than the images from fellow eyes, or the images
would be measured during a particular pulse phase. The peripapillary retinal and rim flow
was measured from the same images focused at the peripapillary retina. This causes the rim
to appear darker, because it is positioned posterior to the focal plane, and subsequently
leads to excessively high flow-values for the rim. To some extent, this effect was reduced
by excluding the nasal retina from the image, which seems to result in more accurate
brightness and flow values for the rim, even though the image is focused upon the
peripapillary retina (Jonescu-Cuypers et al. 2001).
Blue-field entoptoscopy measures leucocyte velocity in the macular vasculature (Riva &
Petrig 1980, Sinclair et al. 1989). The patient adjusts two dials until the velocity and
density of computer-simulated particles displayed on a monitor matches those of her own
entoptically observed leucocytes. This system requires good cooperation from the patient
and is prone to a subjective component. Therefore, only those examinations with
coefficients of variation less than 30% were accepted for analysis. Because poor visual
acuity may also affect results, asymmetry in visual acuity was limited to two Snellen lines,
and no eyes had scotomas within the central 10 degrees.
7.2 RISK FACTORS FOR PROGRESSION (I)
Irrespective of the pathogenesis of glaucoma, the main risk factor to be treated is IOP.
Elevated IOP is the most important risk factor for glaucoma, and relative risk for POAG
has been shown to be increased even at an IOP level of 16 mmHg (Sommer et al. 1991b).
In ExG and POAG, Popovic & Sjöstrand (1999) reported a mean IOP of 16 mmHg after
trabeculectomy in eyes with both progressive and non-progressive VFs, and reported that
IOP level was unrelated to rate of VF progression. This was considered an indicator that
factors other than IOP affected progression. In the present study, survival analysis with the
multivariate Cox proportional hazards model was performed to study factors affecting
progression and it showed that the older the patient, the higher the IOP; and the more
advanced the glaucomatous damage, the more probable was the progression of glaucoma to
another stage. A history of trabeculectomy was associated with decreased relative risk for
progression.
The effect of IOP on progression was clear. Four different variables reflected IOP level:
weighted mean IOP, maximum IOP, mean IOP, and IOP range. In clinical studies, a mean
IOP is often calculated to describe IOP levels during the time of follow-up. Especially in
retrospective follow-up studies, it can be difficult to standardise the length of follow-up
visits and differing numbers of available IOP readings between these visits. Therefore, the
weighted mean IOP was calculated to emphasize IOP levels that had been measured during
longer periods of time, with less weight for IOP levels during shorter periods. This process
was considered to better describe IOP level than a mere calculation of the mean of all IOP
values. According to survival analysis, a one-mmHg increase in weighted mean IOP
increased relative risk for progression by 7.6%. Maximum IOP, mean IOP, and IOP range
did not reach statistical significance in the analysis.
ExG responds well to trabeculectomy (Jerndal & Kriisa 1974, Raitta & Vesti 1991), and
trabeculectomy was found in this study to be associated with decreased risk for
progression. Based on the Cox proportional hazards model, estimated survival curves were
calculated and plotted (Figure 1). Eyes that had been operated on survived progression
longer than those not operated on. At about 13 years there occurred a drop in both survival
curves, and the difference between groups seemed to diminish; only a few patients,
however, had this long a follow-up, and so the estimation may be biased.
Undoubtedly, any beneficial effect of trabeculectomy on glaucoma is mediated through a
reduced IOP. However, because history of trabeculectomy reached statistical significance
in multivariate analysis even though adjusted for mean weighted IOP, some effect from
trabeculectomy must exist separate from weighted mean IOP. One explanation is that after
trabeculectomy, fluctuation in IOP is smaller than in eyes not operated on (Migdal &
Hitchings 1986, Bergeå et al. 1999). A (weighted) mean IOP would remain basically
unaffected in an eye with both high and low IOPs at various times. Thus, a positive effect
of trabeculectomy other than on the weighted mean IOP may be mediated through
decreased variation in IOP compared to that in eyes not surgically treated. It has been
reported that smaller IOP variation is associated with better VF prognosis among patients
with ExG (Bergeå et al. 1999) and POAG (Stewart et al. 1993, Bergeå et al. 1999, Asrani et
al. 2000). Another explanation for the beneficial effect of trabeculectomy may be an effect
mediated through patient compliance. After a successful operation, no glaucoma
medication is needed. In patients using topical medication, IOP level is affected by patient
compliance.
Stage of glaucoma and age of patient were also associated with progression. In clinical
practice it is generally agreed that eyes with far advanced glaucoma are more susceptible to
further VF damage than eyes with early glaucoma (Wilson et al. 1982, Anderson 1989,
Shirakashi et al. 1993, Stewart et al. 1993). This belief is supported by the present findings,
since eyes with advanced VF defects were associated with increased risk for progression.
However, this result may have been biased by the glaucoma grading system used, if the
steps between stages are considered ‘shorter’ in the more advanced stages. The risk for
progression increased also with increasing age, which has also been shown previously
(Kass et al. 1980, Armaly et al. 1980, Quigley et al. 1994, Georgopoulos et al. 1997). No
conclusions as to the mechanism by which stage of glaucoma or patient age affect the
progression can be drawn, but since IOP is the only treatable risk factor, this study supports
lower target pressures in advanced glaucoma and in older patients.
As shown here, total risk for progression is a combination of several risk factors. In clinical
practice, it can be difficult to estimate the risk for progression of individual patients and to
estimate target pressure. In this study, a risk score was calculated based on the four
covariates that reached statistical significance in the Cox proportional hazards model, and
patients were divided into groups with low, medium, and high risk for progression. A risk
score for any patient could be calculated with the same formula in order to determine risk
group. This may prove to be a useful tool for a clinician deciding on whether IOP needs to
be further reduced and whether or not to perform trabeculectomy. That this study was
performed on a selected sample limits the use of the regression coefficients. A similar
formula from a larger and different set of patients should be obtained in a future study.
Moreover, risk factors other than those included in this study may be included.
7.3 ONH MORPHOMETRY (II, III, IV)
Evaluation of the ONH is an essential part of glaucoma diagnosis and follow-up of the
disease. SLO imaging with the HRT allows acquisition of reproducible and reliable images
of the ONH (Mikelberg et al. 1993, Lusky et al. 1993a, Rohrschneider et al. 1994) and in
the present study offered a means for objective and quantitative evaluation of the ONH
topography. The parameters calculated by the software have been shown to be correlated
with VF indices in glaucoma patients (Brigatti & Caprioli 1995, Iester et al. 1997b,e, Eid et
al. 1997b, Tole et al. 1998). There has thus been great interest in studying the capability of
the HRT to differentiate between healthy eyes and eyes with OHT and glaucoma
(Mikelberg et al. 1995, Uchida et al. 1996, Zangwill et al. 1996, Iester et al. 1997a,c,d,
Hatch et al. 1997, Wollstein et al. 1998, Bathija et al. 1998, Mardin et al. 1999). Iester et al.
(1997d) performed receiver operating characteristic (ROC) analysis of the HRT parameters
of 97 glaucoma patients with VF defects and 129 healthy, non-glaucomatous patients. At
best, a sensitivity of 73% and specificity of 73% to differentiate the groups was found for
cup shape measure, and at worst, a sensitivity of 53% and specificity of 60% for height
variation contour. With similar statistics, Uchida et al. (1996) reported their highest
sensitivity and specificity values as being for cup shape measure (83% and 86%,
respectively), to differentiate between glaucoma (with VF damage) and controls. Somewhat
higher sensitivity and specificity have been achieved with combinations of several
parameters (Iester et al. 1997c, Mardin et al. 1999).
In the present study (III), disc area showed an association with most of the HRT
parameters. Interestingly, rim volume, mean cup depth, maximum cup depth, and RNFL
cross-section area appeared to be unaffected by disc area (III), a fact supported by the
findings of others concerning HRT in healthy eyes (Mardin & Horn 1998, Wollstein et al.
1998). The results of the present study support the importance of adjusting for disc area
when comparing HRT values between differing groups of patients. This is also shown by
Wollstein et al. (1998), studying by linear regression analysis the relationship between disc
area and HRT parameters in healthy eyes. They used the 99% prediction interval of the
linear regression to define the normal range of HRT parameters and used it to differentiate
between groups with glaucoma (early VF defect) and normals; when controlling for disc
area, a sensitivity of 84% and specificity of 96% were found for the parameter rim area.
In the present study (IV) with 50 patients with unilateral ExOHT or ExG, all HRT
parameters except maximum cup depth differed significantly between eyes (Table 5).
Furthermore, mean optic disc area was greater in eyes with ExOHT or ExG than in the
fellow eyes. The reason for this is unknown. Mardin & Horn (1998) and Wollstein et al.
(1998), in their studies with HRT, reported no statistically significant differences in disc
area between glaucomatous eyes and healthy eyes, but comparisons were not made between
eyes of the same patient, as was done in this study. Some evidence exists that glaucomatous
eyes have larger optic discs than non-glaucomatous eyes (Healey & Mitchell 1999), and
that eyes with larger discs may be more vulnerable to IOP (Tuulonen & Airaksinen 1992,
Burk et al. 1992, Tomita et al. 1994). However, the discs of both the present study and
fellow eyes (mean ± SD, 1.92 ± 0.41 mm2 and 1.83 ± 0.37 mm2 respectively) seemed to be
small or medium sized rather than large, when compared to the discs measured with HRT
in glaucomatous and healthy eyes by Mardin & Horn (1998) (2.6 ± 0.7 mm2 and 2.6 ± 0.87
mm
2
 respectively) and Wollstein et al. (1998) (1.89 ± 0.34 mm2 and 1.98 ± 0.35 mm2). This
is in accord with the findings of Jonas & Papastathopoulos (1997), who reported smaller
discs in eyes with ExG than in eyes with POAG, and discs smaller in eyes with ExS than in
healthy control eyes. A study of patients with unilateral ExS (Puska & Raitta 1992) found
no difference in disc area between eyes. However, their result may not be comparable to the
result of the present study, because eyes corresponding to the study eyes of this study were
excluded from their study. Bias is possible due to the higher probability that a large disc
will be classified as glaucoma (Heijl & Mölder 1993).
Because of interindividual normal variation in ONH topography and overlap of the HRT
parameters between normal and glaucomatous eyes, no cut-off values for normal ONH
parameters have been established. The most advantageous application of SLO would be its
use in follow-up of patients to aid in detecting change or progression in ONH topography.
In the present study (III), change in VF index MD was examined for any subsequent
associations with change in HRT parameters. Of all HRT parameters, only change in cup
shape measure in a positive direction, indicating ‘more glaucomatous’, was associated with
change in MD to higher values, and vice versa. Change in MD may not be the ideal
measure for progression, since MD has been shown to be sensitive to cataract formation
(Guthauser & Flammer 1988, Yao & Flammer 1993), to long-term fluctuation (Heijl et al.
1987), and to other physiological factors. No actual cut-off criteria for progression based
on a defined change MD was used. Not only was an association between HRT parameters
and MD concerning ‘progression’ studied, but also subsequent ‘improvement’ in HRT
parameters and MD. This may be an advantage when only small overall changes exist in
MD, as in the present study. These results suggest that the cup shape measure may be a
sensitive indicator for progression. Similarly, cup shape measure has been reported to be
one of the best parameters to differentiate among healthy eyes, eyes with OHT, and eyes
with glaucoma (Uchida et al. 1996, Hatch et al. 1997, Iester et al. 1997d, Bathija et al.
1998, Vihanninjoki et al. 2000), and to show correlations with early glaucomatous VF loss
(Mikelberg et al. 1995).
When HRT is used in sequential measurements to evaluate progression of glaucoma, any
effect of change in IOP should be accounted for. Because reduction in IOP can result in
reversal of the ONH topographic parameters (II,III), i.e., changes in a ‘less glaucomatous’
direction, a subsequent rise in IOP may lead to changes in the ONH topography in a ‘more
glaucomatous’ direction without a true loss of nerve fibres. In experimental studies, an IOP
increase has been reported to cause backward bowing of the lamina cribrosa (Levy et al.
1981, Levy & Crapps 1984).
Apart from the present study, few reports exist on the use of HRT in follow-up. Rabinowitz
et al. (1995) followed 44 glaucomatous eyes with cup/disc ratios of ≥ 0.85: 12 eyes
experienced an increase in IOP and/or clinical progression of VF defects. In these 12,
statistically significant changes in cup/disc area ratio, cup area, and rim area were found,
despite the fact that biomicroscopical assessment of the ONH was judged to be unchanged.
Recently, Kamal et al. (1999) reported on changes in HRT parameters in 13 OHT patients
who subsequently developed glaucoma. From the global HRT parameters, they found
significant changes in cup area, cup/disc area ratio, and rim area, but not in cup shape
measure (nor in cup volume or rim volume). However, they did not evaluate change in IOP
during the follow-up period. In another prospective study on eyes with OHT (Kamal et al.
2000), they identified eyes that clinically remained OHT but showed a change in HRT
parameters above the level expected for normal variability. It remains to be seen whether
these eyes later also convert to glaucoma.
Reversal of optic disc cupping after reduction in IOP has been documented in a number of
studies (Quigley 1982, Pederson & Herschler 1982, Shin et al. 1989, Katz et al. 1989, Tsai
et al. 1991, Shirakashi et al. 1992, Sogano et al. 1993, Chavis et al. 1994, Irak et al. 1996,
Park & Hong 1998, Topouzis et al. 1999, Lesk et al. 1999). The most likely physiological
response seems to be reduced backward bowing of the lamina cribrosa (Lusky et al. 1993b,
Sogano et al. 1993, Pederson & Herschler 1982). In the present study, decrease in IOP was
associated with reversal changes in cup area (III), cup/disc area ratio (II,III), rim area (III),
cup volume (II,III), rim volume (III), mean cup depth (II,III), and maximum cup depth
(II,III). HRT parameters such as cup volume and mean and maximum cup depth can easily
be considered to be directly related to the backward bowing of the lamina. However,
reversal in cup area, cup/disc area ratio, rim area, and rim volume after IOP reduction may
indicate that, during periods of elevated IOP, the rim is pulled backward together with the
lamina cribrosa.
Interestingly, cup shape measure seemed to be a sensitive indicator for progression, but was
insensitive to change in IOP (III). It would be an advantage of the cup shape measure if it
proves to be sensitive to progression, i.e., true loss of nerve fibers, but insensitive to change
in IOP. Cup shape measure describes the overall shape of the ONH cupping. It represents
the skewness of the frequency distribution of cup depth values. In normal eyes with their
flat-edged cups and with small depth values most frequent, the frequency distribution is
skewed to the left, and cup shape measure gets a negative value. In glaucomatous eyes with
their steep cups, and with large depth values most frequent, the frequency distribution is
skewed to the right, and cup shape measure gets a positive value. The fact that cup shape
measure was not associated with IOP reduction indicates that the skewness of the
frequency distribution remained unchanged. However, the kurtosis of the frequency
distribution must have changed, because reversal of ONH cupping did occur, as shown by
reversal of other HRT parameters. In other words, after IOP reduction, the number of small
depth values in relation to high depth values remained unchanged, but the number of
intermediate values in relation to small and high values increased.
At least three other studies have recently documented reversal changes shown by the HRT
after reduction in IOP (Table 16) (Irak et al. 1996, Topouzis et al. 1999, Lesk et al. 1999).
The findings of the present study accord best with those of Lesk et al. (1999) who, when
correlating changes in HRT with percentage changes in IOP, found, 6 months after
glaucoma surgery, reversible changes in the same parameters that we did. Irak et al. (1996)
found that percentage changes in IOP correlated with changes in cup shape measure and
RNFL cross-section area, but not with changes in maximum cup depth. No correlation
existed between mean change in IOP and cup volume or rim volume. Topouzis et al. (1999)
compared HRT parameters before and after trabeculectomy, but were unable to correlate
these changes with IOP. Two weeks after treatment they reported reversal changes in some
HRT parameters, but after 4 months only in cup shape measure, and at 8   
Table 16. Reversal changes in HRT parameters in this study and three others
HRT
parameter:
CA C/D RA HVC CV RV MnCD MxCD CSM RNFL1 RNFL2 Comments
Lesk et
al, 1999
Yes Yes Yes No Yes Yes Yes Yes No No No correlation with percent
change in IOP, 6 months
Irak et al,
1996
Yes
(Yes)
Yes
(Yes)
Yes
(Yes)
-
-
Yes
(No)
Yes
(No)
-
-
No
No
Yes
(Yes)
-
-
Yes
(Yes)
correlation with percent
change, and (mean change)
in IOP, 4.5 months
Topouzis
et al,
1999
No
(No)
[No]
No
(No)
[No]
No
(No)
[No]
Yes
(No)
[No]
Yes
(No)
[No]
No
(No)
[No]
yes
(no)
[no]
No
(No)
[No]
Yes
(Yes)
[No]
no
(no)
[no]
No
(No)
[No]
Pairwise comparison before
and after surgery at 2weeks,
(4 months), and [8 months]
Study II -
-
No
Yes
-
-
-
-
Yes
Yes
-
-
Yes
No
-
-
-
-
-
-
-
-
Pairwise comparison before
and after surgery at 4 months
and  (1 year)
Study III Yes Yes Yes No Yes Yes Yes Yes No No No Association with change in
IOP, 6 months
Yes = significant correlation, association, or difference found
No = no significant correlation, association, or difference found
- = did not report
CA = cup area, C/D = cup/disc area ratio, RA = rim area, HVC = Height variation contour, CV = Cup volume, RV = Rim volume, MnCD = Mean cup depth,
MxCD = Maximum cup depth, CSM = Cup shape measure, RNFL1 = Mean RNFL thickness, RNFL2 = RNFL cross section area,
HRT = Heidelberg retina tomograph, IOP = intraocular pressure, RNFL = retinal nerve fibre layer
months in no parameters, although mean IOP was still significantly reduced compared to
pre-operative readings.
Stage of glaucoma was shown to be associated with reversibility of the ONH. In Study III,
stage of glaucoma was included in the analyses and was found to be associated with
reversibility of cup volume and mean cup depth; reversal in these parameters was greater
the more advanced was the glaucoma. In the study with advanced cases (II), reversal
changes could still be detected one year after trabeculectomy, provided that the post-
operative IOP was kept low enough. The results of the present study are contradictive to
those of other studies, in which it has been claimed that with increasing glaucomatous
damage, the reversibility of optic disc cupping decreases (Pederson & Herschler 1982,
Coleman et al. 1991, Shirakashi et al. 1992, Topouzis et al. 1999). Differences may be
methodological and due to the subjects chosen. Topouzis et al. (1999) suggested in their
study that lack of reversal changes in the HRT parameters 8 months after trabeculectomy
may have been due to the advanced glaucoma of their patients. Of their 25 patients, 10 had
POAG, 8 NTG, but only 3 had ExG. The mean (± SD) pre-operative IOP of their patients
was 19.3 ± 6.4 mmHg compared to 28.2 ± 9.0 mmHg in Study III.
The number of patients with cup reversal in the study by Pederson & Herschler (1982) was
small. They reviewed sequential photographs of 259 patients (and an unknown number of
patients in their clinical practices), and found cup reversal in only six eyes, of whom none
were considered as advanced glaucoma. The studies of Coleman et al. (1991) and
Shirakashi et al. (1992) were done on a limited number of monkey eyes (seven and five
eyes, respectively). Further, Coleman et al. (1991) measured acute changes within 15
minutes after IOP reduction, whereas in the present study, changes were measured 3
months to one year after IOP reduction. Zeimer & Ogura (1989) also studied acute changes
but not the reversibility of the ONH topography, rather the acute retrodisplacement of the
ONH surface after IOP increase in post-mortem human eyes. In 15 eyes with VF data
available, they found that the retrodisplacement decreased as the VF worsened, but at only
borderline significance (P < 0.2). Results of histological studies have reported in ExG and
POAG a marked and widespread elastosis (aberrant proliferation and degeneration of
elastic elements) of connective tissue in the lamina cribrosa, and shows that this elastosis is
even more pronounced in ExG than in POAG (Netland et al. 1995, Pena et al. 1998).
Elastosis would lead to increased stiffness of the lamina cribrosa.
Age was also associated with reversibility of cup volume, mean cup depth, and maximum
cup depth. Older patients had greater reversal changes than did younger ones, in accord
with the findings of Lesk et al. (1999). However, their findings concerned only a subgroup
of patients with IOP reduction of 40% or more.
It can be hypothesised (Shin et al. 1989), that reduced backward bowing of the lamina
cribrosa reduces any mechanical stress upon nerve fibres in this region, subsequently
improving axoplasmic transport in the neurons. It remains to be shown whether reversal of
the ONH topography is related to a slower rate of progression of glaucoma. There exist,
however, reports on improved VF indices of eyes in which reversal of disc cupping has
occurred after IOP reduction (Katz et al. 1989, Tsai et al. 1991).
7.4 OCULAR BLOOD FLOW IN ExG (IV, V)
The role of ocular blood flow abnormalities and other vascular risk factors for glaucoma
has attracted increasing interest in the past few years, with recent reviews of ocular blood
flow in glaucoma and various techniques to measure it (Flammer & Orgül 1998, Pillunat
1999, Harris et al. 1999, Anderson 1999). In the present study, ocular blood flow was
measured with scanning laser Doppler flowmetry (the HRF) (IV) and with blue-field
entoptoscopy (V). In ExG, changes in blood flow in the lamina and rim area were found
with the HRF (IV) and in the macular flow with blue-field entoptoscopy (V).
Flow in the rim area in glaucomatous eyes was detected to be higher than in the non-
glaucomatous fellow eyes (IV). Similarly, flow in the laminar area in glaucomatous eyes
was higher than in the fellow eyes, but only at borderline significance (IV). However, the
more advanced the glaucomatous damage, the more reduced was flow both in the laminar
area and in the rim area. This may seem contradictory, but may be explained by
autoregulation of the ONH flow, with upgrading of flow early in the course of glaucoma,
and decrease in flow later in the course, because of breakdown of autoregulation (Pillunat
et al. 1985, Robert et al. 1989, Tielsch et al. 1995). In this study (IV), a large proportion of
the patients had ExOHT (20%) or early glaucoma with glaucomatous ONH changes but a
normal VF (22%).
Previous studies with the HRF have concentrated on healthy eyes and eyes with POAG,
NTG, and OHT, with no reports on eyes with ExG. In patients with POAG, reduced flow
in the laminar (Nicolela et al. 1996b, Kerr et al. 1998, Findl et al. 2000) and rim area
(Michelson et al. 1996a, Kerr et al. 1998, Michelson et al. 1998a, Findl et al. 2000) have
been reported compared to flow in healthy eyes and in eyes with OHT. On the other hand,
some reports have shown no difference in rim area flow between healthy eyes and eyes
with POAG and NTG (Nicolela et al. 1996b, Holló et al. 1997b). Michelson et al. (1996a)
in comparing healthy eyes and eyes with POAG, found a significant correlation between
reduced flow in the rim area and cup/disc ratio; but not, as in the present study, between
reduced flow and MD. Findl et al. (2000) found a significant correlation between reduced
flow in the lamina and MD and between reduced flow in the rim and MD. Reduced ONH
blood flow in POAG has been reported also with types of laser Doppler techniques other
than the HRF (Hamard et al. 1994, Grunwald et al. 1999).
In glaucoma, damage to ganglion-cell axons has been found at the level of the lamina
cribrosa (Gaasterland et al. 1978, Quigley et al. 1981). Thus, an association between
glaucoma and deficiency in blood flow in this area can be expected, but one may question
the relevance of measuring retinal, choroidal, or retrobulbar flow. There are, however,
several studies in which parameters of blood flow have been detected to be altered in the
peripapillary retina (Nicolela et al. 1996b, Michelson et al. 1996a, Michelson et al. 1998a,
Chung et al. 1999), macula (Sponsel et al. 1990, Sponsel et al. 1997), choroid (Trew &
Smith 1991, Fontana et al. 1998), and retrobulbar arteries (Rojanapongpun et al. 1993, Butt
et al. 1995, Kaiser et al. 1997, Butt et al. 1997, Yamazaki & Drance 1997) in patients with
POAG and NTG when compared to parameters of healthy eyes and eyes with OHT.
In the present study (IV), no difference in peripapillary retinal flow appeared between eyes
with ExG and their non-glaucomatous fellow eyes, nor was there any association between
peripapillary flow and amount of glaucomatous VF or ONH damage (IV). Controversially,
some studies have reported decreased flow in the peripapillary retina in eyes with POAG,
compared to flow in healthy eyes (Nicolela et al. 1996b, Michelson et al. 1996a, Michelson
et al. 1998a). However, Kerr et al. (1998) have reported increased minimum velocity in the
temporal retina of eyes with POAG compared to velocity in eyes with OHT, and Holló et
al. (1997a,b) found ‘high’ flow values to be more frequent in glaucomatous eyes than in
healthy ones (Holló et al. 1997a). In the present study, mean macular leucocyte velocity
was statistically significantly lower in eyes with ExG than in their non-glaucomatous non-
exfoliative fellow eyes (V). In six patients, leucocyte velocity was lower in the
glaucomatous eye, and in two patients lower in the fellow eye. However, differences in
leucocyte velocity between the eyes were greater when the glaucomatous eye had the lower
flow (26-50%), compared to the two cases in which the leucocyte velocity was lower in the
healthy eye (15% and 18%). Further, only glaucomatous eyes showed a negative
correlation (with borderline significance) between leucocyte velocity and MD, and between
leucocyte velocity and LV (V). When leucocyte velocity in all four groups of eyes is
compared, it seems that only the non-glaucomatous eyes in unilateral ExG differed from the
others, having higher (mean ± SD, 0.89 ± 0.34 mm/s) leucocyte velocity than the
glaucomatous eye (0.70 ± 0.25 mm/s), and higher than the exfoliative and non-exfoliative
eyes in unilateral ExS (0.72 ± 0.15 mm/s and 0.70 ± 0.21 mm/s respectively). However,
comparison between these separate groups of patients may be inappropriate, because of
differences in systemic diseases and medications, and differences in how patients perform
the subjective measurement. This was the reason for the choice of patients with unilateral
ExG and ExS. The results of the present study are in accord with the results of Sponsel et
al. (1990, 1997) who also studied macular circulation with blue-field entoptoscopy, but in
patients with POAG. Similarly to the present study with ExG (V), they found a correlation
between macular leucocyte velocity and VF indices; reduced leucocyte velocity was
associated with increased VF damage.
Overall, in only a few works has ocular blood flow been measured in eyes with ExS or
ExG. Sibour et al. (1997) studied choroidal blood flow with a pulsatile ocular blood flow
(POBF) system in nine patients with unilateral ExS. Their mean POBF was 14% lower in
the exfoliative eyes than in the non-exfoliative fellow eyes. Repo et al. (1995) performed
color Doppler ultrasound measurements of the ophthalmic artery in 32 healthy individuals
(64 eyes) and in 46 patients (92 eyes) who had suffered TIA. They found a high frequency
of ExS among patients who had suffered TIA and had positive iris transilluminance. Those
patients also had higher resistivity indices of the ophthalmic arteries than did healthy
subjects without iris transilluminance. A vessel diameter can be considered only an indirect
measurement of blood flow; however, the diameter of the retinal arterioles at the disk
border has been reported to be smaller in POAG and ExG than in normal eyes (Jonas &
Papastathopoulos 1997).
It remains to be determined whether in glaucoma reduced ocular blood flow is a cause or a
consequence. Another issue in ExG is whether similar pathophysiology is behind the
reduced flow, as in other types of OAG, or whether reduced flow is in some way connected
with the presence of exfoliation material; in the iris, the vasculopathy associated with ExS
(Ringvold 1970, Ringvold & Davanger 1981, Konstas et al. 1993b, Asano et al. 1995,
Kivelä et al. 1997) has also been associated with anterior segment ischaemia (Vannas 1969,
Helbig et al. 1994). In 11 eyes with unilateral ExS, no difference was found in macular
leucocyte velocity between exfoliative eyes and non-exfoliative fellow eyes (V). Of the
fellow eyes in Study IV, 36 were clinically exfoliative and 14 clinically non-exfoliative.
The diagnoses of the fellow eyes (exfoliative or non-exfoliative) were included in the
multivariate analyses of difference in flow between glaucomatous and non-glaucomatous
eyes, but they seemed to have no association with lamina, rim, or peripapillary flow.
Therefore, this association between glaucomatous damage and blood flow (IV, V) can be
considered to be associated with the glaucomatous defect and not with the presence of ExS.
However, this does not exclude the possible effect of ExS per se on ocular blood flow. It is
possible that also in the early course of ExS vasculopathy has some effect on ocular blood
flow, but later, when the vasculopathy is more severe or has persisted longer, it begins to
cause damage to the nerve fibres, damage which can be detected and diagnosed as
glaucoma. Further, a difference in flow due to exfoliation material may be difficult to
detect in a study comparing exfoliative eyes and non-exfoliative fellow eyes, because the
clinically non-exfoliative eyes may also be exfoliative if examined electron microscopically
or immunohistochemically (Schlötzer-Schrehardt et al. 1991, Kivelä et al. 1997). Perhaps
comparison would be more appropriate between patients with ExS and patients without
ExS in either eye.
The effect of topical β-blocking agents on ocular blood flow is an important issue. In Study
IV, topical treatment with timolol was associated with reduced blood flow in the lamina
and rim area. This was apparent both in analyses of differences in flow between
glaucomatous eyes and the non-glaucomatous fellow eyes, and in analyses of glaucomatous
eyes only. Between peripapillary flow and treatment with timolol, no association appeared.
Macular leucocyte velocity was statistically significantly lower in glaucomatous eyes than
in their fellow eyes (V). All 10 glaucomatous eyes were treated with timolol, and therefore
any effect of timolol on the results cannot be excluded. However, treatment with timolol
does not explain the correlation (though of borderline significance) between leucocyte
velocity and VF indices. Thus, treatment with timolol seems to be associated with reduced
flow in the ONH, but not in the peripapillary retina or macula. This issue has been studied
extensively. Several studies report timolol treatment to be associated with decreased ocular
blood flow values (Richard & Weber 1987, Van Buskirk et al. 1990, Langham 1990,
Yoshida et al. 1991, Boles Carenini et al. 1994, Nicolela et al. 1996a, Schmetterer et al.
1997), but opposite findings also exist (Jay et al. 1984, Grunwald 1986, Baxter et al. 1992),
and reports of no effect at all (Green & Hatchett 1987, Harris et al. 1995, Morsman et al.
1995, Wang et al. 1997, Holló et al. 1997b, Michelson et al. 1998a).
Timolol is a non-specific β-adrenergic blocker with effects both on β1 and on β2 receptors.
In the eye, β-adrenoreceptors of mainly the β2-subtype have been demonstrated in the
anterior part of the optic nerve and ONH (Dawidek & Robinson 1993), choroid (Grajewski
et al. 1991), retinal blood vessels (Denis et al. 1990), and ciliary body (Wax & Molinoff
1987). No conclusion can be drawn as to whether reduced blood flow in the lamina and rim
area is mediated through blockade of the β2 receptors in the ONH (Dawidek & Robinson
1993), but this is at least possible. Diffusion of topically applied timolol to the posterior
pole of the eye is uncertain, but after topical administration of radio-labeled timolol to
rabbit eyes, it has been measured in the choroid, retina, and vitreous (Schmitt et al. 1980).
Topically applied timolol has also been shown to cause vasoconstriction of retinal vessels
(Martin & Rabineau 1989) and of the arteries that supply the ciliary processes (Van
Buskirk et al. 1990). The ocular β2 receptors can also be reached through the systemic
circulation. Topically applied timolol can be absorbed into the systemic circulation (Schmitt
et al. 1980, Vuori et al. 1993, Uusitalo et al. 1999). Drug concentrations of clinical
significance in the contralateral eye may be reached after topically applied timolol (Saari et
al. 1993), as shown by lowering of IOP also in the contralateral eye (Radius et al. 1978). A
crossover effect of timolol on the ocular blood flow may also occur, but this would have
diminished the difference in flow that was found between the eyes (IV). In the examination
of study eyes only, treatment with a systemic β-blocker may also have confounded the
results. Of 50 patients, 8 were receiving a systemic β-blocker for some systemic condition
(IV), but no statistically significant effect of this appeared in the multivariate analyses.
In short, exfoliation glaucoma often shows an aggressive clinical course. Good control of
intraocular pressure is required, especially in elderly patients and patients with more
advanced disease. New imaging methods, such as scanning laser ophthalmoscopy, may
offer tools for more sensitive evalution of the optic nerve head and its progression. Even
though considered a secondary glaucoma, it seems that exfoliation glaucoma is a matter not
only of increased intraocular pressure, but also of altered ocular blood flow.
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